UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K/A10-K

(Amendment No. 1)

(Mark One)

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED JUNE 30, 20202023

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________ TO __________

COMMISSION FILE NUMBER: 000-54437

SUNHYDROGEN, INC.

(NameExact name of registrant as specified in its charter)

NEVADANevada26-4298300
(State or other jurisdiction of

incorporation or organization)
(I.R.S. Employer

Identification No.)

BioVentures Center, 2500 Crosspark Road, Coralville, IA 52241

10 E. Yanonali St., Suite 36 Santa Barbara, CA 93101

(Address of principal executive offices) (Zip Code)

Issuer’sRegistrant’s telephone Number:number, including area code (805)805) 966-6566

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
NoneNoneNone

Securities registered pursuant to section 12(g) of the Act: common stock, par value $0.001 per share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐  No ☒

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerAccelerated Filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

The aggregate market value of the common stock held by non-affiliates of the registrant, based upon the last sale price of the common stock of the Companyregistrant as of the last business day of its most recently completed second fiscal quarter was approximately $6,059,344.$111,249,945.

The number of shares of registrant’s common stock outstanding, as of September 18, 202028, 2023 was 2,156,132,155.5,061,034,972.

DOCUMENTS INCORPORATED BY REFERENCE

None

 

TABLE OF CONTENTS

   Page

Explanatory Note

The purpose of this Amendment No. 1 (the “Amendment”) to the Annual Report on Form 10-K of SunHydrogen, Inc. (the “Company”) for the year ended June 30, 2020 (the “Original Form 10-K”) is to change the location of the going concern paragraph in the audit report of the Company’s independent registered public accounting firm, so that it appears immediately following the opinion paragraph. In connection with the filing of this Amendment, the Company is also including with this Amendment certain currently dated certifications and consents. Except as otherwise set forth in this Explanatory Note, no other information included in the Original Form 10-K is amended or changed by this Amendment.

TABLE OF CONTENTS

  PagePART I
 PART I 
Item 1.Business1
Item 1A.Risk Factors610
Item 1B.Unresolved Staff Comments15
Item 1C.Cybersecurity15
Item 2.Properties1015
Item 3.Legal Proceedings1015
Item 4.Mine Safety Disclosures1015
   
 PART II 
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities1116
Item 6.[Reserved.]Selected Financial Data1217
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations1217
Item 7A.Quantitative and Qualitative Disclosures about Market Risk.1419
Item 8.Financial Statements and Supplementary Data1419
Item 9.Changes In and Disagreements with Accountants on Accounting and Financial Disclosure1419
Item 9A.Controls and Procedures1420
Item 9B.Other Information.1520
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections20
   
 PART III 
Item 10.Directors, Executive Officers and Corporate Governance1621
Item 11.Executive Compensation1723
Item 1212.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters1825
Item 13.Certain Relationship and Related Transactions, and Director Independence1926
Item 14.Principal Accountant Fees and Services1926
PART IV
Item 15.Exhibit and Financial Statement Schedules27
Item 16.ExhibitsForm 10-K Summary2028
   
SIGNATURES22

 29 

i

 

 

PART I

Item 1. Business.

Unless otherwise stated or the context requires otherwise, references in this annual report on Form 10-K to “SunHydrogen”, the “Company”, “we”, “us”, or “our” refer to SunHydrogen, Inc.

Overview

At SunHydrogen, our goal is to replace fossil fuels with clean, renewable hydrogen.

Our patented low-cost technologyHydrogen is intendedthe most abundant chemical element in the universe. When hydrogen fuel is used to produce renewable hydrogen using sunlightpower transportation and any source ofindustry, the only byproduct left behind is pure water, including seawater and wastewater. Unlike non-renewableunlike hydrocarbon fuels such as oil, coal and natural gas wherethat emit carbon dioxide and other contaminants are releasedharmful pollutants into the atmosphere when used, hydrogen fuel produces pure water as the only product. By optimizing the science of photoelectrolysis at the nano-level, our low-cost nanoparticles mimic photosynthesis to efficiently use sunlight to split water molecules into renewable hydrogen. Using our low-cost method to produce renewable hydrogen, we intend to enable a world of distributed hydrogen production for renewable electricity and hydrogen fuel cell vehicles.

Hydrogen is the lightest and most abundant chemical element, constituting roughly 75% of the universe’s chemical elemental mass (Palmer, D. (13 September 1997). “Hydrogen in the Universe.” NASA). In its purest form, hydrogen is a non-toxic colorless and odorless gas.atmosphere. However, naturally occurring elemental hydrogen is relatively rare on earth and hydrogen gas is most often produced using fossil fuels. Industrial production– so rare, in fact, that today about 95% of all hydrogen is mainlyproduced from the steam reforming of natural gas (Source: US Department of Energy, Hydrogen Fuel Basics). This process is both economically and is usually employed near its production site, with the two largest applications being crude oil processing (hydrocracking) and ammonia production, mostly for the fertilizer market. environmentally unsound.

We are developing whata technology that we believe is a cleanerhas the potential to offer an efficient and greenercost-effective way to produce hydrogen.

Hydrogen astruly green hydrogen using sunlight and any source of water. Just like a fuel, likesolar panel is comprised of multiple cells that generate electricity, is an energy carrier ratherour hydrogen panel encases multiple hydrogen generators immersed in water. Each hydrogen generator contains billions of electroplated nanoparticles, autonomously splitting water into hydrogen and oxygen. Our technology has the potential to be one of – if not the most – economical green hydrogen solutions: Unlike traditional water electrolysis for hydrogen, our process requires no external power other than an energy source. We believe that if hydrogen was easily accessible for the world to depend on it, the challenging global issues associated with the widespread usages of fossil fuels, such as global climate changesunlight and air pollution would be erased.

Over 99% of hydrogen produced today is produced using a fossil fuel, methane (natural gas) in a method called steam methane reforming (SMR). Although commercially optimized over decades, the SMR process is capital intensiveuses efficient and will remain so due to the fundamental nature of the process which includes: (1) three separate reactors with different catalysts operating at different temperatures, (2) large amounts of heat transfer needed for the endothermic reforming and exothermic water gas shift, and (3) the need to remove all carbon oxides using capital and energy intensive methods. (source: Nikolaidis, P.; Poullikkas, A., A comparative overview of hydrogen production processes. Renewable and Sustainable Energy Reviews 2017, 67, 597-611.)low-cost materials.

Besides being capital intensive, the SMR method releases harmful levels of carbon dioxide and other pollutants into the air further contributing to our global climate crisis.

We believe renewable hydrogen ishas already proven itself to be a key solution in helping the fuel ofworld meet climate targets, and we believe our technology potentially offers solutions to the future. The main challenge has beenchallenges that the highhydrogen future presents, including cost of hydrogen production and transportation. Many of today’s green hydrogen producers transport their product over long distances, so although the hydrogen itself is green, the delivery and transport infrastructure comes with a high carbon footprint and a significant capital investment. The SunHydrogen solution is fully self-contained, offering on-site solar hydrogen generation and local distribution to eliminate carbon footprint altogether and significantly reduce capital investments for transport and delivery.

Additionally, because our process directly uses the electrical charges created by sunlight to generate hydrogen, our nanoparticle technology does not rely on grid power or require the costly power electronics that conventional electrolyzers do.

With a target cost of $2.50/kg., we believe our solution has the potential to clear a path for green hydrogen to compete with natural gas hydrogen and gain mass market acceptance as a true replacement for fossil fuels.

Our technology is primarily developed at our independent laboratory in Coralville, Iowa. Development efforts are also aided by our sponsored research agreements with the University of Iowa and the University of Michigan, and by our relationships with specialized industry partners.

The 2023 fiscal year saw our Coralville, Iowa laboratory space grow with the addition of talented engineers and chemists, state-of-the-art equipment, and a demonstration-ready setup fit for presenting our process to new and existing industrial partners.

Led by Chief Scientific Officer Dr. Syed Mubeen and Director of Technology Dr. Joun Lee, our Iowa team is focused on building tandem photoelectrosynthetic heterostructures (nanoparticle-based tandem semiconductor units) and evaluating their manufacturability at scales relevant for commercialization. This involves porous substrate fabrication and development of SunHydrogen’s two proprietary semiconductor nanoparticle units within these porous substrates (dual junction devices).


In the past year, our Iowa team has achieved several key milestones toward commercialization. Namely, we have:

(1) Unveiled the largest version to-date of SunHydrogen’s nanoparticle-based green hydrogen technology, featuring 16-times more hydrogen generator area than the previous small-scale model. The 1.5 sq. ft. prototype is currently the only self-contained nanoparticle-based hydrogen generation device of its kind that splits water molecules into high-purity hydrogen and oxygen using the sun’s energy.

(2) Achieved open circuit photovoltages over 0.9 volts with a single-junction semiconductor unit; open circuit photovoltages over 1.8 volts with a dual-junction semiconductor unit; and photocurrent densities as high as 13.2 milliamps per square centimeter per substrate with a single-junction semiconductor unit. These results confirm that SunHydrogen has consistently reached commercializable photovoltages and photocurrent densities using our nanoparticle units.

 While the above accomplishments provide encouragement that we are on the right track toward our goal of delivering the most affordable green hydrogen solution, we remain focused on the additional milestones we must meet to reach commercialization.

Foremost, to achieve commercially-viable solar-to-hydrogen efficiency targets, we require a second junction unit capable of producing photocurrent densities similar to or higher than our first junction, which we are currently working toward. Our team is currently pursuing multiple approaches to bolster our operational photocurrent densities, and our next milestone is translating our existing lab-scale success to larger scales.

In parallel, we are optimizing our panel design to increase hydrogen production rates and durability while decreasing the cost per kilogram of hydrogen produced. We believeare working to increase the hydrogen generator area to panel area ratio, minimize voltage loss, and improve power conversion efficiency.

Led by Dr. Nirala Singh, one of the lead inventors on SunHydrogen Patent No. 9,593,053B1, the University of Michigan team is focused on understanding the requirements of the generator housing including hydrogen collection efficiency and optimizing and testing potential oxygen evolution and hydrogen evolution electrocatalysts to accelerate scaleup and increased efficiency of photoelectrochemically active heterostructures.

In the past year, they identified the most promising configurations to minimize the significant energy losses and produce hydrogen at a low-cost distributed productionhigh rate. They further tested these configurations in the Generator Housing with oxygen evolution and hydrogen evolution catalysts synthesized in the previous year and measured the collection efficiency of hydrogen following its production. The stability of the hydrogen evolution catalyst and oxygen evolution catalyst synthesized in the previous year were also evaluated for continuous operation in a three-electrode setup. University of Michigan is developing strategies to mitigate the high series resistance in the device and improved the kinetics of the oxygen evolution electrocatalyst to lower the overpotentials while maintaining high stability of the catalyst.

University of Michigan demonstrated the use of the system in the Generator Housing without membranes while maintaining a low crossover of the generated gases. The elimination of the membrane can assist with reducing capital and processing costs. University of Michigan also tested the ionic and liquid crossover of the membrane integrated configuration fabricated by partners. They evaluated the ionic conductivity as well as mechanical, chemical, and electrochemical stability.

To evaluate the hydrogen collection efficiency, University of Michigan integrated a gas collection system to the Generator Housing. This system underwent successive modifications to increase efficiency of hydrogen collection process to match the desired values motivated by technoeconomic analysis. Consequently, a high faradaic efficiency of hydrogen generation process with high hydrogen collection efficiency was successfully achieved.

University of Michigan also identified various voltage losses in the Generator Housing and compared with the model values calculated in the previous year. The oxygen evolution catalyst and series resistance in the device were identified as two major sources of voltage loss.


Outside of our central research and development hub in Iowa and our work with the University of Iowa and the University of Michigan, we have further expanded our industrial partnerships across the U.S., Germany, South Korea, and Japan.

Our current industrial partners include: COTEC Corp.; MSC Co. LTD; Chromis Technologies; the National Renewable Energy Laboratory (NREL); Geomatec; and InRedox. By diversifying our commercialization strategy in this way, we have formed relationships with industrial partners who are specialized in individual components of our technology such as electroplating, substrate processing and catalyst/membrane integration.

InRedox and Geomatec are focused on facilitating our transition to large-scale substrate manufacturing, while MSC Co. LTD is focused on developing large-scale electroplating chemistries.

With the SunHydrogen technology,National Renewable Energy Agency, we are working to improve the overall power conversion efficiency of our hydrogen panels.

With COTEC Corp. we are working to reproduce existing lab-scale achievements using industrial electroplating processes. We expect our initial exploration phase with COTEC to be completed by December 31, 2023. Following this phase, our next step is to produce 1m² hydrogen panels to be utilized in multiple commercial-scale pilot projects.

We are working with Chromis Technologies to integrate both proton exchange membranes (PEM) and anion exchange membranes (AEM) into our proprietary substrates and evaluate performance metrics for sustainable hydrogen production.

We also recently announced the approval of $3.1M in funding for Project NanoPEC, which brings us together with six partners at the cutting edge of industry and science in Germany, including: SCHMID Group; Fraunhofer; WAVELABS Solar Metrology Systems GmbH; ECH Elektrochemie Halle GmbH; Zahner-Elektrik; and Helmholtz-Zentrum Berlin.

We believe working with some of the most innovative leaders in German industry and science can accelerate our progress toward commercialization.

Finally, we remain well-capitalized to pursue strategic investments in the hydrogen space, as evidenced by our November 2022 investment of $10M in Norway-based TECO2030 ASA.

With their zero-emission PEM hydrogen fuel cells stacks and modules, TECO2030 ASA is accelerating the transition to clean energy in the maritime and heavy-duty transportation sectors, and has formed strong relationships with world-leading companies in the fuel cell industry in the process. Their longtime development partner AVL is the wayworld’s largest independent company for the development, simulation and testing of powertrain systems. TECO 2030 ASA is also partnered with thyssenkrupp Automation Engineering, which holds over 100 years of fuel cell experience and €34 billion in revenue in 2021.

Every day in the US, hundreds of thousands of diesel-powered trucks travel through routes with abundant land and sun. Envision SunHydrogen panels along and around these highways, producing green hydrogen at and near refueling sites: Our technology would eliminate the need to enabletransport hydrogen fuel over long distances, lowering the high costs and hydrogen losses that would otherwise happen in long-distance transport. In the future, we believe our green hydrogen panels along major trucking routes worldwide, together with the proliferation of TECO 2030 ASA ’s hydrogen fuel cell technology, can make a worldsignificant mark on the industry.

While we remain dedicated to our primary goal of cleandeveloping our nanoparticle technology to commercialization, we will also seek to further the renewable hydrogen ecosystem through investment in, and renewable energy.

Market Opportunity

acquisition of, complementary hydrogen technologies. We believe we have the resources to maximize our impact in this fast-growing industry.


Additionally, we believe our recent uplisting to the OTCQB Venture Market will allow us to expose a broader range of investors to our mission of producing low-cost, truly green hydrogen. With additional compliance and quality standards, the OTCQB provides investors improved visibility to enhance trading decisions.

Looking ahead to the upcoming months, we continue making steady progress toward strengthening our operational photocurrent densities, optimizing our panel design, and engaging quality manufacturing partners that can take our existing lab-scale process to commercial-scale.

Market Opportunity

Hydrogen generation is projected to become a $1 trillion per year market by 2050 (Source: Goldman Sachs, Carbonomics: The clean hydrogen revolution). Current fossil fuels can’t sustain future energy requirements environmentally or economically, and hydrogen fuel technologies are stillbeing adopted across all sectors as the world moves toward renewable alternatives.

Over 110 countries have set goals to achieve net-zero emissions by 2050, and as governments are looking to clean energy sources like hydrogen to help them meet their targets (Source: United Nations, The race to zero emissions, and why the world depends on it). It is estimated that nearly 25% of global energy will come from clean hydrogen alone by 2050 (Source: Goldman Sachs, Green Hydrogen: The next transformational driver of the Utilities industry).

In the US, California is leading the way in hydrogen strategies, with more fuel cell passenger vehicles on the road than any other state and one of the largest hydrogen refueling station networks in the early stagesworld (Source: Sierra Nevada Ally, Hydrogen Fuel Cell Vehicles are Building Momentum in California). Globally, over 1,000 green hydrogen production demonstration projects have been announced around the world, and policy leaders have put forth ambitious strategies to utilize hydrogen and fuel cell technologies across all sectors of the economy including transportation, feedstock and industrial heat use (Source: The Hydrogen Council and McKinsey & Company, Hydrogen Insights 2023).

Existing Market Growth

As supply chain challenges and geopolitical conflicts continue to affect fuel prices globally, the hydrogen market is rallying support from consumers and yet, thisgovernments alike.

In August 2022, The Inflation Reduction Act, which allotted $369 billion to renewable energy and climate projects, was signed into law in the US. “Among its features, the law has a 10-year extension of solar and wind tax credits and incentives to support new technology, with hydrogen and energy storage set to be the greatest beneficiaries,” according to Morningstar’s chief US market continuesstrategist Dave Sekera (Source: Markets Insider, Clean energy stocks are set to grow exponentially. Onebe the big winners of the reasonssweeping Inflation Reduction Act just signed by Biden, Morningstar says). Specifically, the Act included a tax credit that will award up to $3/kg for this growth islow carbon hydrogen, with exact credit amounts to be determined by calculating a given project’s greenhouse gas emissions (Source: S&P Global, Hydrogen tax credits preserved in new US Inflation Reduction Act).

In the year since the passage of the Inflation Reduction Act, the US has seen additional promising legislation in favor of the adoption of hydrogen fuel technologies withinas a replacement for fossil fuels. Most recently, the US Department of Energy released its intent to invest up to an increased number of major industriesadditional $1 billion to support the Regional Clean Hydrogen Hubs program, an already-$7 billion initiative to create six to ten regional clean hydrogen hubs across the country (DOE, Biden-Harris Administration to Jumpstart Clean Hydrogen Economy with New Initiative to Provide Market Certainty and spanning many applications.

Furthermore, recent government mandates for renewable energy have created a real and sustainable market opportunity for renewable hydrogen. Most states in the United States have legislative mandates to use between 10-45% of renewable energy by 2050, some states have mandates for 100% by 2050. These include California (100% by 2045), Colorado (100% by 2050), Hawaii (100% by 2045), Virginia (100% by 2050), Washington (100% by 2045), Washington DC (100% by 2032) and Puerto Rico (100% by 2050)Unlock Private Investment). (https://www.ncsl.org/research/energy/renewable-portfolio-standards.aspx)

While solar and wind electricity have been the dominate form of renewable energy, the sun does not always shine and the wind does not always blow. Therefore, we believe a direct solar-to-hydrogen technology which immediately stores solar energy as hydrogen can turn solar energy into a primary and reliable source of energy just like coal and natural gas – but cleaner and greener.

Existing Market Growth

According to a Global Market Insights study released in June 2019,the DOE, America’s growing hydrogen economy has the potential to add 100,000 net new direct and indirect jobs by 2030 (DOE, DOE’s Pathways to Commercial Liftoff: Clean Hydrogen report).

An additional factor currently driving the global hydrogen generation market size is predicted to be valued at $180 billion by 2024. Strict regulatory normsthe need to reduce sulfur content with measures to reduce the carbon footprint is expected to drive the global hydrogen generation market size.in petroleum products. U.S. federal and state governments have adopted various programs, including the Tier 3 program, to reduce the sulfur content in gasoline, motor oil and diesel and which aims to lower the gasoline sulfur content up to 10 ppm in 2017.

1

Growingdiesel. Particularly, there is a growing demand for petroleum products from developing countries is anticipated to also drive the hydrogen generation market size in the coming years.countries. Hydrogen is used in various refining processes including hydrocracking and hydrodesulfurization to crack bigger molecules into lighter ones and produce more usable products.


 

Strong investment for the expansion

For all these reasons and upgrade of refineries to fulfill emission and sulfur content regulation is expected to stimulate the growth of the hydrogen generation market. Increasing heavy crude oil consumption demand will complement the industry landscape. Positive outlook towards the chemical industry including ammonia and methanol will also positively influence growth.

We believe increasing demand for clean fuel energy will be affected by:

Stringent government regulation towards Desulphurization of Petroleum Products

Deteriorating crude oil quality

Transportation & Storage Issues

It is within these industries thatmore, we believe our renewable hydrogen producinghydrogen-producing technology possesses significant early market opportunity, especially as innovation and infrastructure continue to develop.

Utility Scale Hydrogen Electricity

According to a March 2013 report from NREL, a national laboratory of the U.S. Department of Energy, Hydrogen can be blended into the existing natural gas pipeline networks, thus bypassing the high cost of dedicated hydrogen pipelines in order to use hydrogen at a large scale. If implemented with relatively low concentrations, less than 5%–15% hydrogen by volume, this strategy of storing and delivering renewable hydrogen to markets appears to be viable without significantly increasing risks associated with utilization of the gas blend in end-use devices (such as household appliances), overall public safety, or the durability and integrity of the existing natural gas pipeline network. (https://www.nrel.gov/docs/fy13osti/51995.pdf).

Hydrogen Fuel Cell VehiclesMobility

One ofThe auto-manufacturing and vehicle industries are among the most recognized applications for hydrogen fuel technologies falls within the auto manufacturing and vehicles industries. The three leading manufacturers oftechnologies. According to a 2023 study by Information Trends, over 56,000 hydrogen fuel cell vehicles (FCVs)had been sold by year-end 2022 (Source: Information Trends, Global Market for Hydrogen Fuel Cell Vehicles).

Historically, sales have been held back due to the lack of a solid hydrogen refueling infrastructure, but the numbers are in order, Toyota, Hyundai,projected to rise quickly, and Honda – three internationally recognized companies. Industry reports cite the need for increased infrastructure, such as fueling stations, for the industry to garner even greater market acceptance. However, the same report indicates there will be 22.2 million hydrogen fuel cell vehicles soldare gaining momentum around the world. Specifically, hydrogen stands to make a significant impact on the heavy-duty, long-haul trucking industry. Hydrogen-powered trucks and hydrogen refueling stations present a variety of cost, scalability, and sustainability-related benefits over battery power, according to a recent McKinsey & Company report. Namely, hydrogen-fueled trucks can refuel faster and carry a lower weight penalty than battery-powered trucks because tanks weigh considerably less than batteries. And at scale, the infrastructure is less costly to create than e-truck charging infrastructure because it does not require grid upgrades and has a smaller carbon footprint. Faster refueling speed also means the hydrogen infrastructure can be used by many more trucks (McKinsey & Company, Unlocking hydrogen’s power for long-haul freight transport).

Additionally, hydrogen has emerged as an ideal solution for a myriad of mobility-related applications beyond fuel cell cars and trucks.

In a 2022 report from the Ocean Conservancy, researchers concluded that green hydrogen-based fuels are the best option to transition the shipping industry away from fossil fuels. “Producing green hydrogen-based fuels can kickstart the transition to new shipping fuels along promising green corridor routes within the U.S. and can make key down payments that will drive further investment in renewable energy and feed the demand for climate action within the global transportation sector,” said Daniel Hubbell, shipping emissions campaign manager for Ocean Conservancy (Source: Ocean Conservancy, Green Hydrogen-Based Fuels are the Best Option to Transition the Shipping Industry Away from Fossil Fuels, New Report Finds).

In March 2023, French rail transport manufacturing company Alstom announced the debut of North America’s first green hydrogen-powered train, which began transporting passengers this summer (Smithsonian Magazine, North America’s First Hydrogen-Powered Train Will Debut This Summer). This follows Germany’s monumental 2022 accomplishment of completing the first-ever rail line to be entirely run on hydrogen-powered trains. Germany’s hydrogen trains have a range of 1,000 kilometers, meaning they can run for an entire day on the network on a single tank of hydrogen, and a hydrogen filing station has already been established on the route (Source: CNN, The world’s first hydrogen-powered passenger trains are here).

Hydrogen is even powering factory forklifts for commerce leaders like Walmart and Amazon: In 2022, Walmart purchased hydrogen from Plug Power to fuel as many as 9,500 machines across the retailer’s fulfillment and distribution centers (Source: Bloomberg, Walmart Will Run Forklifts on ‘Green’ Hydrogen in Plug Power Deal). In August 2023, Walmart opened a green hydrogen plant with energy company Engie at its Quilcura distribution center in Chile, in alignment with its desire to replace lead-acid batteries in forklifts with hydrogen fuel cells. “We are moving away from lead-acid batteries to reduce the time our associates spend on the battery charge process, which we expect will now improve up to 80%,” a company spokesperson said (Source: Hydrogen Insight, Walmart replaces battery-electric forklifts with hydrogen fuel-cell models to reduce charging times).

Amazon and Plug Power have entered a similar agreement, with Plug Power providing Amazon with 10,950 tons of liquefied hydrogen per year that will be used to fuel transportation and building operations starting in 2025 (Source: Forbes, Amazon To Buy Plug Power’s ‘Green’ Hydrogen In Deal with $2.1 Billion Stock Option). Along with fuel for forklifts, Amazon may also use hydrogen to power a range of vehicles used in delivery operations, including long-haul trucks, the article stated.


Whether in traditional vehicles, marine ships, long-haul trucks, trains, or leased by 2032, driving revenues upwardseven factory forklifts, it is clear that hydrogen has already made a significant mark on the mobility industry, and we only expect it to become more prolific as governments continue to support the development of $1.1 trillion. (https://www.researchandmarkets.com/reports/4200873/global-market-for-hydrogen-fuel-cell-vehicles).relevant infrastructure that the hydrogen future calls for.

Our Technology

Technology for Making Renewable Hydrogen from Sunlight and Water

Hydrogen (H2)Powered by solar energy, billions of our microscopic nanoparticles split apart water at the molecular level, extracting hydrogen for use as a clean energy source and leaving behind only clean oxygen as a byproduct. This process is similar to what happens inside a plant cell during photosynthesis: Each Photoelectrosynthetically Active Heterostructures (or PAH) nanoparticle is a microscopic machine, composed of multiple layers enabling the third most abundant element on earth and the cleanest fuel in the universe, (Dresselhaus, Mildred et al. (May 15, 2003). “Basic Research Needs for the Hydrogen Economy”). Unlike hydrocarbon fuels such as oil, coal and natural gas where carbon dioxide and other contaminants are released into the atmosphere when used, hydrogen fuel usage produces only pure water (H2O). Unfortunately, nearly no pure hydrogen exists naturally on earth and therefore must be extracted from hydrogen containing molecules like water. Historically, the cost of manufacturing hydrogen as an alternative fuel has been higher than the cost of the energy usedsolar electrolysis reaction to make it. This is the dilemma of the hydrogen economy, and one that we aim to address.

For over a century, water electrolysis, splitting water molecules into hydrogen and oxygen due to the passage of electric current, has been a well-established technology to produce hydrogen. The produced hydrogen combusts into water that can be recycled back into nature indefinitely. However, in practice, current commercial water electrolysis technologies require considerable energy from coal-powered electricity and also require ultra-pure water to prevent fouling of the system components. We believe these are the major barriers to affordable production of hydrogen.

The Perfect and Sustainable Energy Cycle

As it turns out, Mother Nature has been making hydrogen using sunlight since the beginning of time by splitting water molecules (H2O) into its basic elements - hydrogen and oxygen. This is exactly what plant leaves do every day by way of photosynthesis. Since the produced hydrogen is immediately consumed inside the plant, we cannot simply grow trees to make hydrogen.

If technology can be developed to mimic photosynthesis to split water into hydrogen, we believe then a truly sustainable, low cost, and renewable energy cycle can be created to power the earth. However, cost has been the biggest barrier to realizing this vision.

take place.

2

Water Splitting

In the process of splitting a water molecule, input energy is transferred into the chemical bonds. So in essence,Essentially, manufactured hydrogen is simplyserves as a carrier or battery-like storage of the input energy. If the input energy is from fossil fuels, such as oil and gas, then carbon fossil fuel energy is simply transferred into hydrogen. If the input energy is renewable, such as solar andor wind, then new and clean energy is stored in hydrogen.

While the concept of water splitting is very appealing, the following industry-wide challenges must be addressed for renewable hydrogen to be commercially viable:

Energy Inefficiency — Since hydrogen is an energy carrier, the most energy it can store is 100% of the input energy. However, conventional systems approach to electrolysis methods lose so much of the input energy in system components, wires and electrodes resulting in only a small portion of electricity making it into the hydrogen molecules. This translates to high production cost and is the fundamental problem with water splitting for hydrogen production. We intend to address this problem with our low costlow-cost and energy efficient particleenergy-efficient nanoparticle technology.

Need for Clean Water — Conventional electrolysis requires highly purified clean water to prevent fouling of system components. This prevents current technology from using large quantities of available water from oceans, rivers, industrial waste and municipal waste as feedstock. Our technology is being designedWe are currently working with acidic or alkaline water, as well as wastewater, to use any natural water or waste water for the unlimited production ofproduce renewable hydrogen.hydrogen through our nanoparticle technology.

 

Technology

Water electrolysis in its simplest form is the transfer of “input electrons” in the following chemical reactions:

Cathode (reduction): 2H2O + 2ee--®H +2+ 2OH-

2OH-

Anode (oxidation): 4OH-® O4OH- 2+ 2H2O + 4 ee--

From these equations, one can deduce that if every input electron (e-) is put to work and not lost, then a maximum amount of input electrons (i.e. energy) is transferred and stored in the hydrogen molecules (H2). Additionally, if there were a very high number of cathode and anode reaction areas within a given volume of water, then a very high number of these reactions could happen simultaneously throughout the medium to split each water molecule into hydrogen wherever electrons are available.


 

SunHydrogen Panel™

Since our particles are intended to mimic the natural temperature conditionsprocess of photosynthesis, directly producing hydrogen and oxygen without the need for costly intermediate power conversions, they can be housed in very low-cost reactors. To facilitate the commercial use of our self-contained particle technology, we are developing a modular system that will enable the onsite daily production and storage of hydrogen for any timeany-time use in electricity generation.

We refer to our potential product as the SunHydrogen Panel which is comprised of the following components:

1.The Panel Housing - Novel (patent pending) device design is the first of its type to safely separate oxygen and hydrogen in the water splitting process without sacrificing efficiency. This device houses the water, the solar particles/cells and is designed with inlets and outlets for water and gasses. Utilizing a special membrane for separating the oxygen side from the hydrogen side, proton transport is increased which is the key to safely increasing solar-to-hydrogen efficiency. Our design can be scaled up and manufactured for commercial use.

2.

The NanoParticle or Solar Cell - Our patented Our patented Photoelectrochemically Active Heterostructures (PAH) consists of billions of tiny solar cells in 1cm2 that are electrodeposited into a protective structure to provide the charge that splits the water molecules.

In the process of optimizing our nanoparticles to be efficient and only use earth abundant materials (an ongoing process), we experimented with commercially available triple junction silicon solar cells to perform tests with our generator housing and other components. Through this experimentation, our discovery leads us to believe that we can bring a system to market utilizing these readily available cells while our nanoparticles are still being optimized. These solar cells also absorb the sunlight and produce the necessary charge for splitting the water molecules into hydrogen and oxygen.

3.Oxygen Evolution Catalyst - This proprietary catalyst developed at the University of Iowa is applied on the solar cell or nanoparticle and efficiently oxidize water molecule to generate oxygen gas. The oxygen evolution catalyst must be robust to withstand the long operating hours of the hydrogen generation device to ensure long lifetime. It is designed to be efficient and stable in alkaline environments.

4.Hydrogen Evolution Catalyst - Necessary for collecting electrons to reduce protons for generating hydrogen gas, we have successfully developed a process to integrate an ultra-low loading of platinum hydrogen catalyst on foam electrodes at ten times lower loading with over 67 times higher activities.

3

5.Coating Technologies - Two major coating technologies were developed to protect the nanoparticles and solar cells from photo-corrosion under water. A transparent conducive coating to protect our nanoparticles and solar cells from photo corrosion and efficiently transfer charges to catalysts for oxygen and hydrogen evolution reactions. A polymer combination that protects the triple junction solar cells from any corrosive water environments for long lifetime of the hydrogen generation device.

1. The Generator Housing - Our novel device design is the first of its kind to safely separate oxygen and hydrogen in the photoelectrochemical process, minimizing the sacrifice of solar-to-hydrogen efficiency. This device houses the water and the solar particles/cells and is designed with inlets and outlets for water and gasses. Utilizing a novel ion-exchange membrane integration strategy for separating the oxygen from the hydrogen products, efficient ion transport safely enables efficient solar hydrogen production.

6.A concentrator equal to two suns - This inexpensive Fresnel lens concentrator to increase sunlight to equal two suns reduces our necessary footprint for a 1000 KG per day system by 40%.

2. The NanoParticle or Solar Cell - Powered by solar energy, billions of our microscopic nanoparticle solar cells split apart water at the molecular level, extracting hydrogen for use as a clean energy source and leaving behind only clean oxygen as a byproduct.

3. Oxygen Evolution Catalyst - Uniformly applied to the solar cell or nanoparticle, an oxygen evolution catalyst efficiently oxidizes water molecules to generate oxygen gas. The oxygen evolution catalyst must be robust to withstand long operating hours under acidic and alkaline conditions.

4. Hydrogen Evolution Catalyst - Necessary for collecting electrons to reduce protons for generating hydrogen gas, we have identified a strategy to minimize the use of precious metal-based catalysts and integrated the hydrogen catalyst into our generator system for efficient solar hydrogen production.

5. Coating Technologies - Two major coating technologies were developed to protect the nanoparticles and solar cells from photocorrosion under water: A transparent conductive coating to protect our nanoparticles and solar cells from photocorrosion during the water splitting process and efficiently transfer charges to catalysts for oxygen and hydrogen evolution reactions; and a polymer combination that protects the semiconductor solar cells that would otherwise fail in aquatic environments, instead ensuring a long lifetime for solar hydrogen production.

Our business and commercialization plan calls for two generations ofutilizes our panels or generators. The first generation being manufactured for demonstration utilizes readily available commercial solar cells, coated with a stabilizing polymer and catalysts, and inserted into our proprietary panels to efficiently and safely split water into hydrogen and oxygen to produce very pure and green hydrogen that can be piped off the panel, pressurized, and stored for use in a fuel cell to power anything electric.

The second generation of our panels will feature a nanoparticle-based technology, where billions of autonomous solar cells are electrodeposited onto protective porous alumina sheets and manufactured in a roll to roll process or wafer process and inserted into our proprietary panels. For this generation,our nanoparticle technology, we have received multiple patents and we estimate that it will produceour target cost of hydrogen for less than $4production is $2.50 per kilogram before pressurization.

Our team atIn addition to our sponsored research agreements with the University of Iowa led by our CTO Dr. Joun Lee, has reached a milestoneand University of well over 1000 consecutive hours of continuous hydrogen production utilizing completely immersed solar cells with no external biases achieving simulated production equal to one year. We believe this to be a record for completely immersed cells. Now ready to take our technology out of the lab,Michigan, we are working with several vendorsa growing group of specialized industrial partners to help commercialize and manufacturer our first generation of renewable hydrogen panels that use sunlight and water to generate hydrogen. Our current industrial partners include: COTEC Corp.; MSC Co. LTD; Chromis Technologies; the National Renewable Energy Laboratory (NREL); Geomatec; and InRedox. Our project partners through Project NanoPEC include: SCHMID Group; Fraunhofer; WAVELABS Solar Metrology Systems GmbH; ECH Elektrochemie Halle GmbH; Zahner-Elektrik; and Helmholtz-Zentrum Berlin.


 

We anticipate that the SunHydrogen Panel will be a self-contained renewable hydrogen production system that requires only sunlight and any source of water.  As a result, it can be installed almost anywhere to produce hydrogen fuel at or near the point of distribution, for local use. We believe this model of hydrogen production addresses one of the biggest challenges of using clean hydrogen fuel on a large scale which is the transportation of hydrogen.

Each stage of the SunHydrogen Panel can be scaled independently according to the hydrogen demands and length of storage required for a specific application. A small-scale system can be used to produce continuous renewable electricity for a small house, or a large scale system can be used to produce hydrogen to power a community.

SunHydrogen Panel Manufacturing

We are currently working towards producing 100 demonstration SunHydrogen Panels, that will be used to display our Gen 1 technology in a number of venues throughout the United States and internationally. We anticipate that these demonstration panels will broaden national and global awareness of our new, green hydrogen generating technology. With the resulting increased interest, potential customers of our technology will be able to observe the panels’ operation first hand, and determine potential uses in their business operations.

Intellectual Property

On November 14, 2011, we filed a provisional patent application with the U.S. Patent and Trademark Office to protect the intellectual property rights for “Photoelectrochemically“Photoelectrosynthetically Active Heterostructures, methods for their manufacture, and methods and systems for producing desired products.”Heterostructures” A year later on November 14, 2012, we filed a non-provisional application claiming priority to the provisional application. On March 14, 2017, the part of thea first patent covering the structural design of PhotoelectrochemicallyPhotoelectrosynthetically Active Heterostructures (PAH) was granted as the United States Patent No. 9,593,053B1. OnA divisional application claiming priority to the foregoing applications was filed, and on April 3, 2018, the part of thea second patent covering the method for manufacturing PAH was granted as United States Patent No. 9,593,053B2. The patent protectsThese patents protect the Company’s proprietary design and manufacturing method of a self-contained solar-to-hydrogen device made up of millionsbillions of solar-powered water-splitting nanoparticles, per square centimeter. These nanoparticles are coated withseparated by a separate patent-pending protective coating that prevents corrosion during extended periods of hydrogen production. The aim of producing these nanoparticles is to achieve high solar -to-hydrogen conversion efficiency andat low cost. These patents expire on November 14, 2032.

An important aspect of the patented technology referred to in the preceding paragraph is the integrated structures of high-density arrays of nano-sized solar cells as part of hydrogen production nanoparticles. The technology enables manufacturing of ultra-thin sheets for solar-to-hydrogensolar hydrogen production, requiring substantially less material as compared to conventional solar cells used in rooftop power applications. 

InOn March of 2015,21, 2014, we jointly filed a full utility patentprovisional application with UCSBthe University of California, Santa Barbara for the “Multi-junction artificial photosynthetic cell with enhanced photovoltages.” The patent coversThereafter, we filed a non-provisional application on March 16, 2015 and a corresponding PCT Application on March 17, 2015. These applications cover our semiconductor designs to enhance the photovoltages of the nano-sized solar cells in the PAH structures. The semiconductor designs stacking multiple junctions inside the PAH structures would be an efficient and economiceconomical solution for the photovoltaic and the photoelectrochemical industries. This patent wasPatents were granted in Australia in April of 2018, China and Europe in March of 2019, and in the U.S. as United States Patent No. 10,100,415 in October of 2018. The last patent from this international application was granted in India in October 2022. This patent expires on October 21, 2036.

On December 21,September 26, 2016, we filed jointly with the University of Iowa a patentprovisional application for “Integrated Membrane Solar Fuel Production Assembly” to protect the intellectual property for our generator housing system that safely separates oxygen and hydrogen in the water-splitting process without sacrificing efficiency. This device houses the water, the solar particles/cells and is designed with inlets and outlets for water and gases. Utilizing a special membranearchitecture that integrates membranes for separating the oxygen side from the hydrogen side, proton transport is increased which is the key to safely increasing solar-to-hydrogen efficiency. InOn September of26, 2017, we filed a PCT Application that was later nationalized in the utilityU.S. on March 26, 2019. The U.S. patent application for this important invention is pending and prosecution is ongoing.

 

4

 

 

Strategic Partners

Effective September 1, 2020, we entered intoWe are currently engaged in a sponsored research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either party upon 60 days prior written notice or by either party upon notice of a material breach or default which is not cured within 90 days of receipt of written notice of such breach. This term of the research agreement runs through August 31, 2021September 30, 2023 but may be extended upon mutual agreement of the parties.

We are currently engaged in a sponsored research agreement with the University of Michigan. This term of the research agreement runs through September 30, 2023 but may be extended upon mutual agreement of the parties.

We have also initiated a research agreement with the National Renewable Energy Laboratory (NREL). This research agreement runs through April 21, 2024, but may be extended upon mutual agreement of the parties.

Additionally, we are engaged in an ongoing consulting contract with Strategic Analysis, Inc. to aid in further reducing our system cost through techno-economic research and evaluation.

In February 2021, we entered into a cooperation agreement with SCHMID Group of Freudenstadt, Germany. Through the collaboration, we identified key manufacturing needs in the areas of electroplating chemistries, substrate processing and membrane and catalyst integration that require collaboration with specialized industry partners. To address these scale-up challenges, we have since adopted a more diversified scale-up strategy. Due to delays associated with supply chain challenges brought on by the Covid-19 pandemic, the cooperation agreement was extended to fully complete the work scope with no additional cost to the company. Our agreement with SCHMID Group remains open-ended, and we look forward to ongoing collaboration with SCHMID through Project NanoPEC on the design and engineering of our generator housing.

Competition

Currently, most hydrogen is produced by steam reforming of natural gas or methane. This production technology dominates due to easy availability and low prices of natural gas. Partial oxidation of petroleum oil is second in production capacity after steam reforming of natural gas. The third largest production technology in terms of production capacity is steam gasification of coal. The currentKey players in the traditional hydrogen production industry is heavily dominated by large players such asinclude Linde, Air Liquide, Air Products, Praxair, and Chemicals Inc. and Air Liquide.more.

At this time, however, we view our primary competition as companies that have developed or are currently developing renewable hydrogen production technology. Green or Renewablerenewable hydrogen can be produced through electrolyzers if theythe electrolyzers are powered by renewable energy sources, such as solar or wind. There has been an emergenceSome of these companies include:

Plug Power: Plug Power (Stock symbol: PLUG) is engaged in the past few years.development of hydrogen fuel cell systems that replace conventional batteries in equipment and vehicles powered by electricity. The company is currently building green hydrogen plants to produce at least 70 tons of liquid green hydrogen daily by the end of 2022 and 500 tons daily by 2025.

NEL Hydrogen: NEL Hydrogen (Stock symbol: NLLSF) delivers solutions to produce, store, and distribute hydrogen from renewable energy. The company’s hydrogen solutions cover the entire value chain from hydrogen production technologies to hydrogen fueling stations, enabling industries to transition to green hydrogen.

Fusion Fuel: Fusion Fuel (Stock symbol: HTOO) has developed a modular solar to hydrogen solution, combining proven solar concentration technology with a proprietary micro-electrolyzer that allows it to produce zero-emissions green hydrogen at highly competitive costs. The company sells its HEVO-Solar technology to customers interested in producing their own green hydrogen. It also develops company-owned green hydrogen farms.

ITM Power: ITM Power (Stock symbol: ITMPF) designs, manufactures, and integrates electrolyzers based on proton exchange membrane technology to produce green hydrogen using renewable electricity and tap water. ITM Power works with strategic partners including Linde, Shell, Snam, Hyundai, and Honda to scale its impact and industrial reach.

McPhy: McPhy (Stock symbol: MCPHY) specializes in Englandthe design, production and Proton Onsiteintegration of high pressure alkaline electrolyzers and hydrogen stations. McPhy has five development, engineering and production sites in Norway are two of the largest companies in this industry. France, Italy, and Germany, and it is backed by solid and constantly-evolving European industrial foundations.


If not powered by solar panels or wind power, theyrenewable sources, electrolyzers require external electricity most likely created by coal, gas or oil. We believe that our process when fully developed willmay potentially offer a competitive advantage as we anticipate it is completely green andwill be fully renewable and utilizesutilize no external power other than the sun. However, it should be noted that the renewable hydrogen market is rich with competitors, like the companies mentioned above, who have already successfully commercialized green hydrogen production technologies. We anticipate that existing leaders will continue to hone the efficiency of their products and drive down cost of green hydrogen per kilogram, thus creating a more competitive, challenging environment for emerging, not-yet-commercialized technologies such as our own.

Corporate Information

We were incorporated in the State of Nevada on February 18, 2009. Our executive offices are located at 10 E. Yanonali St., Suite 36, Santa Barbara, CA 93101.2500 Crosspark Road, Coralville IA 52241.

Employees

As of September 18, 2020,27, 2023, we had one (1)have 8 full-time employeeemployees and several consultants. We have not experienced any work stoppages and we consider relations with our employees and consultants to be good. Our Chief Technology Officer hired on June 1, 2016 is on a fulltime consulting basis. Most of our research and development work is performed byat our Coralville, Iowa laboratory, as well as with the University of Iowa and the University of Michigan through a sponsored research agreement. 

agreements, and in collaboration with our industrial partners.

5

Item 1A. Risk Factors.

Risks related to our business and industry

Our limited operating history does not afford investors a sufficient history on which to base an investment decision.

We were formed in February 2009 and are currently developing a new technology that has not yet gained market acceptance. There can be no assurance that at this time we will ever operate profitably or that we will have adequate working capital to meet our obligations as they become due.

Investors must consider the risks and difficulties frequently encountered by early stage companies, particularly in rapidly evolving markets. Such risks include the following:

competition;
need for acceptance of products;
ability to continue to develop and extend brand identity;
ability to anticipate and adapt to a competitive market;
ability to effectively manage rapidly expanding operations;
amount and timing of operating costs and capital expenditures relating to expansion of our business, operations, and infrastructure; and
dependence upon key personnel.

We cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event that we do not successfully address these risks, our business, prospects, financial condition, and results of operations could be materially and adversely affected and we may have to curtail our business.


 

We have a history of losses and have never realized revenues to date. We expect to continue to incur losses and no assurance can be given that we will realize revenues. Accordingly, we may never achieve and sustain profitability.

As of June 30, 2020,2023, we have an accumulated deficit of $75,550,515.$81,971,040. For the year ended June 30, 20202023 we incurredhad net income of $974,979 due to a net loss of $57,529,338.non-cash change in derivatives. We expect to continue to incur net losses until we are able to realize revenues to fund our continuing operations. We may fail to achieve any or significant revenues from sales or achieve or sustain profitability. Accordingly, there can be no assurance of when, if ever, we will be profitable or be able to maintain profitability.

We have historically raised funds through various capital raising transactions. We will require additional funds in the future to fund our business plans, either through additional equity or debt financings or collaborative agreements or from other sources. We have no commitments to obtain such additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all. During the year ended June 30, 2023, the Company received funds through an equity purchase agreement in the net amount of $2,733,494. In the event we are unable to obtain additional financing, we may be unable to implement our business plan. Even with such financing, we have a history of operating losses and there can be no assurance that we will ever become profitable.

We may be unable to manage our growth or implement our expansion strategy.

We may not be able to develop our product or implement the other features of our business strategy at the rate or to the extent presently planned. Our projected growth will place a significant strain on our administrative, operational and financial resources. If we are unable to successfully manage our future growth, establish and continue to upgrade our operating and financial control systems, recruit and hire necessary personnel or effectively manage unexpected expansion difficulties, our financial condition and results of operations could be materially and adversely affected.

We may not be able to successfully develop and commercialize our technologies which would result in continued losses and may require us to curtail or cease operations.

In May of 2012, we completed a labWe are currently working to scale prototypethe lab-scale prototypes of our technology. This prototype demonstrates hydrogen production from small scale solar devices coated with our unique, low-cost polymer coating, and submerged in waste water from a pulp and paper mill.nanoparticle technology to larger, commercial-scale prototypes. However, we have not completed a large-scale commercial prototype of our technology and are uncertain at this time when completion of a commercial scale prototype will occur. Although the lab scale prototype demonstrates the viability of our technology, there can be no assurance that we will be able to commercialize our technology.

6

Our revenues will be dependent upon acceptance of our products by the market; the failure of which would cause us to curtail or cease operations.

We believe that virtually all of our revenues will come from the sale or license of our products. As a result, we will continue to incur substantial operating losses until such time as we are able to develop our product and generate revenues from the sale or license of our products. There can be no assurance that businesses and customers will adopt our technology and products, or that businesses and prospective customers will agree to pay for or license our products. Our technology and product, when fully developed, may not gain market acceptance due to various factors such as not enough cost savings between our method of producing hydrogen and other more conventional methods. In the event that we are not able to significantly increase the number of customers that purchase or license our products, or if we are unable to charge the necessary prices or license fees, our financial condition and results of operations will be materially and adversely affected.


 

We anticipate that we will face intense competition, and many of our competitors have substantially greater resources than we do.

 

We operate in a competitive environment that is characterized by price fluctuation and technological change. We anticipate that we will compete with major international and domestic companies. Some of our current and future potential competitors may have greater market recognition and customer bases, longer operating histories and substantially greater financial, technical, marketing, distribution, purchasing, manufacturing, personnel and other resources than we do. In addition, competitors may be developing similar technologies with a cost similar to, or lower than, our projected costs. As a result, they may be able to respond more quickly to changing customer demands or to devote greater resources to the development, promotion and sales of solar and solar-related products than we can.

Our business plan relies on sales of our products based on either a demand for truly renewable clean hydrogen or economically produced clean hydrogen. If we fail to compete successfully, our business would suffer and we may lose or be unable to gain market share. Neither the demand for our product nor our ability to manufacture at commercial scale have yet been proven.

Because our industry is highly competitive and has low barriers to entry, we may lose market share to larger companies that are better equipped to weather a deterioration in market conditions due to increased competition.

Our industry is highly competitive and fragmented, subject to rapid change and has low barriers to entry. We may, in the future, compete for potential customers with solar and heating companies and other providers of solar power equipment or electric power. Some of these competitors may have significantly greater financial, technical and marketing resources and greater name recognition than we have.

We believe that our ability to compete depends in part on a number of factors outside of our control, including:

the ability of our competitors to hire, retain and motivate qualified personnel;
the ownership by competitors of proprietary tools to customize systems to the needs of a particular customer;
the price at which others offer comparable services and equipment;
the extent of our competitors’ responsiveness to customer needs; and
installation technology.

Competition in the solar power services industry may increase in the future, partlyCurrently, competing methods of hydrogen production include steam reforming of natural gas or methane, which dominates due to its easy availability and low barriers to entry, as well as from other alternative energy resources now in existenceprice; partial oxidation of petroleum oil; steam gasification of coal; and electrolyzers powered by solar or developed in the future. Increased competition could result in price reductions, reduced margins or loss of market share and greater competition for qualified personnel.wind energy. There can be no assurance that we will be able to compete successfully against current and future competitors. If we are unable to compete effectively, or if competition results in a deterioration of market conditions, our business and results of operations would be adversely affected.

Our business depends on proprietary technology that we may not be able to protect and may infringe on the intellectual property rights of others.

Our success will depend, in part, on our technology’s commercial viability and on the strength of our intellectual property rights. We currently hold patents in the US, China, Australia, and Australia,Europe but still have several patents pending in multiple countries.  There is no guarantee the pending patents will be granted. In addition, any agreements we enter into with our employees, consultants, advisors, customers and strategic partners will contain restrictions on the disclosure and use of trade secrets, inventions and confidential information relating to our technology may not provide meaningful protection in the event of unauthorized use or disclosure.

Third parties may assert that our technology, or the products we, our customers or partners commercialize using our technology, infringes upon their proprietary rights. We have yet to complete an infringement analysis and, even if such an analysis were available at the current time, it is virtually impossible for us to be certain that no infringement exists, particularly in our case where our products have not yet been fully developed.

7


 

We may need to acquire licenses from third parties in order to avoid infringement. Any required license may not be available to us on acceptable terms, or at all.

We could incur substantial costs in defending ourselves in suits brought against us for alleged infringement of another party’s intellectual property rights as well as in enforcing our rights against others, and if we are found to infringe, the manufacture, sale and use of our or our customers’ or partners’ products could be enjoined. Any claims against us, with or without merit, would likely be time-consuming, requiring our management team to dedicate substantial time to addressing the issues presented. Furthermore, the parties bringing claims may have greater resources than we do.

We do not maintain theft or casualty insurance and only maintain modest liability and property insurance coverage and therefore, we could incur losses as a result of an uninsured loss.

We do not maintain theft, casualty insurance, or property insurance coverage. We cannot assure that we will not incur uninsured liabilities and losses as a result of the conduct of our business. Any such uninsured or insured loss or liability could have a material adverse effect on our results of operations.

If we lose key employees and consultants or are unable to attract or retain qualified personnel, our business could suffer.

Our success is highly dependent on our ability to attract and retain qualified scientific, engineering and management personnel. We are highly dependent on our CEO, Timothy Young, and our development team at the University of Iowa. The loss of this valuable resource could have a material adverse effect on our operations. Our only officer is employed on “at will” basis. Accordingly, thereThere can be no assurance that they will remain associated with us. Our management’s efforts will be critical to us as we continue to develop our technology and as we attempt to transition from a development stage company to a company with commercialized products and services. If we were to lose Mr. Young or the services of the development team at the university or any other key employees or consultants, we may experience difficulties in competing effectively, developing our technology and implementing our business strategies.

The loss of strategic alliances used in the development of our products and technology could impede our ability to complete our product and result in a material adverse effect causing the business to suffer.

We pursue strategic alliances with other companies in areas where collaboration can produce technological and industry advancement. WeFor example, we have entered into thea sponsored research agreement with the University of IowaMichigan which is set to terminate August 31, 2021.September 30, 2023. If we are unable to extend the terms of thethis agreement, or any of our other agreements with our partners as described in this report, we could suffer delays in product development or other operational difficulties which could have a material adverse effect on our results of operations.

There is substantial doubt about our ability to continue as a going concern.

Our independent public accounting firm in their report dated September 23, 2020 included an explanatory paragraph expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. Going concern contemplates the realization of assets and the satisfaction of liabilities in the normal course of business over a reasonable length of time. Our ability to continue as a going concern ultimately is dependent on our ability to generate a profit which is dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. As a result, our financial statements do not reflect any adjustment which would result from our failure to continue to operate as a going concern. Any such adjustment, if necessary, would materially affect the value of our assets.

An occurrence of an uncontrollable event such as the covid-19The COVID-19 pandemic may negatively affect our operations.

The occurrence of an uncontrollable event such as the COVID-19 pandemic may negatively affect our operations. The COVID-19 pandemic has resulted in social distancing, travel banshad widespread, rapidly evolving, and quarantine,unpredictable impacts on global society, economies, financial markets, and this has limitedbusiness practices. The continuing impacts of COVID-19 are highly unpredictable and could be significant, and may continue to limit access tohave an adverse effect on our facilities bybusiness, operations and our management, support staff and professional advisors. These factors, in turn, may not only impact our operations,future financial condition and development of our products but our overall ability to react timely to mitigate theperformance.

The impact of this event. Also, it may hamperthe pandemic on our effortsbusiness, operations and future financial performance could include, but is not limited to, comply with our filing obligations with the Securities and Exchange Commission, and our ability to raise capital on favorable terms, or at all.that:

We may experience delays in our product development;

The rapid and broad-based shift to a remote working environment creates inherent productivity, connectivity, and oversight challenges; and

Volatility in the equity markets could affect the value of our equity to shareholders and have an impact on our ability to raise capital. 

8


 

Risks relating to our common stock

There is a limited trading market for our common stock.

Our common stock is not listed on any national securities exchange. Accordingly, investors may find it more difficult to buy and sell our shares than if our common stock was traded on an exchange. Although our common stock is quoted on the OTC Pink,OTCQB , it is an unorganized, inter-dealer, over-the-counter market which provides significantly less liquidity than the Nasdaq Capital Market or other national securities exchange. Further, there is limited trading in our common stock. These factors may have an adverse impact on the trading and price of our common stock.

Our common stock could be subject to extreme volatility.

The trading price of our common stock may be affected by a number of factors, including events described in the risk factors set forth in this report, as well as our operating results, financial condition and other events or factors. In addition to the uncertainties relating to future operating performance and the profitability of operations, factors such as variations in interim financial results or various, as yet unpredictable, factors, many of which are beyond our control, may have a negative effect on the market price of our common stock. In recent years, broad stock market indices, in general, and smaller capitalization companies, in particular, have experienced substantial price fluctuations. In a volatile market, we may experience wide fluctuations in the market price of our common stock and wide bid-ask spreads. These fluctuations may have a negative effect on the market price of our common stock. In addition, the securities market has, from time to time, experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock.

There is a large number of authorized but unissued shares of capital stock available forWe anticipate that our issuance which may result in substantial dilution to existing shareholders.

Our articles of Incorporation authorized the issuance of up to 5,000,000,000 shares of common stock par value $0.001 and 5,000,000upon conversion of Series C Preferred Shares will result in dilution to our stockholders.

As of June 30, 2023, we have outstanding shares of redeemable Series C Preferred Stock with an aggregate stated value of $1,095,100 that are convertible into common stock at a fixed conversion price of $0.00095 (see Note 3 to the financial statements included in this report). We anticipate that our issuance of common stock upon conversion of outstanding preferred shares will result in dilution to holders of our common stock, par value $0.001,which may have a negative effect on the price of which 2,156,132,155our common stock. In addition, as of June 30, 2023, we have outstanding warrants to purchase 86,495,239 shares of common stock and no shares of preferred stock are outstanding as of September 18, 2020. Our Board of Directors has the abilityoptions to authorize the issuance of an additional 2,843,867,845purchase 163,894,499 shares of common stock, and 5,000,000our issuance of shares of preferredcommon stock without shareholder approval. Any such issuance willupon exercise of outstanding warrants or options may result in substantialadditional dilution to existing shareholders. In addition, the availability of such a large number of capital stock could be utilized, under certain circumstances, as a method of discouraging, delaying or preventing a change in control of the Company.our stockholders.

We have never paid common stock dividends and have no plans to pay dividends in the future, as a result our common stock may be less valuable because a return on an investor’s investment will only occur if our stock price appreciates.

Holders of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid no cash dividends on our shares of common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future. We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any return investors in our common stock will be in the form of appreciation if any, in the market value of our shares of common stock. There can be no assurance that shares of our common stock, will appreciate in value or even maintain the price at which our stockholders have purchased their shares.may not occur.

Our common stock is subject to the SEC’s penny stock rules.

Unless our common stock is listed on a national securities exchange, including the Nasdaq Capital Market, or we have stockholders’ equity of $5,000,000 or less and our common stock has a market price per share of less than $5.00, transactions in our common stock will be subject to the SEC’s “penny stock” rules. If our common stock remains subject to the “penny stock” rules promulgated under the Securities Exchange Act of 1934, broker-dealers may find it difficult to effectuate customer transactions and trading activity in our securities may be adversely affected.

9


 

In accordance with these rules, broker-dealers participating in transactions in low-priced securities must first deliver a risk disclosure document that describes the risks associated with such stocks, the broker-dealer’s duties in selling the stock, the customer’s rights and remedies and certain market and other information. Furthermore, the broker-dealer must make a suitability determination approving the customer for low-priced stock transactions based on the customer’s financial situation, investment experience and objectives. Broker-dealers must also disclose these restrictions in writing to the customer, obtain specific written consent from the customer, and provide monthly account statements to the customer. The effect of these restrictions will probably decrease the willingness of broker-dealers to make a market in our common stock, decrease liquidity of our common stock and increase transaction costs for sales and purchases of our common stock as compared to other securities. Our management is aware of the abuses that have occurred historically in the penny stock market.

This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.

Our articles of incorporation allow for our board to create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights of the holders of our common stock.

Our board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of directors has the authority to issue up to 5,000,000 shares of our preferred stock without further stockholder approval. As a result, our board of directors could authorize the issuance of a series of preferred stock that would grant to holders of preferred stock the right to our assets upon liquidation, or the right to receive dividend payments before dividends are distributed to the holders of common stock. In addition, our board of directors could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or that is convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.

Additional stock offerings in the future may dilute then-existing shareholders’ percentage ownership of the Company.

Given our plans and expectations that we will need additional capital, and personnel, we anticipate that we will need to issue additional shares of common stock or securities convertible or exercisable for shares of common stock, including convertible preferred stock, convertible notes, stock options or warrants. TheWe anticipate that our issuance of additional common stock or securities convertible into or exercisable into common stock in the future will dilute the percentage ownership of then current stockholders.

Item 1B. Unresolved Staff Comments.

None.

Item 1C. Cybersecurity.

Not applicable.

Item 2. Properties.

Our principal office address is 10 E. Yanonali, Suite 36, Santa Barbara, CA, 93101. We believe that our current premisesand independent laboratories are sufficient to handle our administrative activities forlocated at the near future as adequate lab space and equipment is attained through our agreement with the University of Iowa.BioVentures Center at 2500 Crosspark Rd., Coralville, IA 52241.

Item 3. Legal Proceedings.

We are not currently a party to, nor is any of our property currently the subject of, any material legal proceedings.

Item 4. Mine Safety Disclosures.

Not Applicable.

 

Not Applicable.

10

 

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock is quoted on the OTC PinkOTCQB under the symbol “HYSR”

SecuritiesCommon Stock

Our Articles of Incorporation, as amended, authorizes the issuance of 5,000,000,00010,000,000,000 shares of common stock, $0.001 par value per share and 5,000,000 shares of preferred stock, par value $0.001 per share.

All outstanding shares of common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of our stockholders. All stockholders are entitled to share equally in dividends, if any, as may be declared from time to time by the Board of Directors out of funds legally available. In the event of liquidation, the holders of our common stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders do not have cumulative or preemptive rights.

As of September 18, 2020,22, 2023 our common stock was held by 178approximately 194 stockholders of record.

Dividend Policy

We have never declared or paid any cash dividends on our common stock. We do not anticipate paying any cash dividends to stockholders in the foreseeable future. In addition, any future determination to pay cash dividends will be at the discretion of the Board of Directors and will be dependent upon our financial condition, results of operations, capital requirements, and such other factors as the Board of Directors deem relevant. There are no restrictions in our articles of incorporation or bylaws that restrict us from declaring dividends.

Equity Compensation Plan Information

On January 23, 2019, our Board adopted the Company’s 2019 Equity Incentive Plan (the “Plan”). The stated purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The maximum number of shares of the Company’s common stock that can be issued under the Plan is 300,000,000.

The following table sets forth information about our equity compensation plans as of June 30, 2020.

Plan Category Number of
securities to
be issued
upon
exercise of
outstanding
options,
warrants
and rights
  Weighted-
average
exercise
prices of
outstanding
options,
warrants
and rights
  Number of
securities
remaining
available for
future
issuance
under the
equity
compensation
plans
(excluding
securities
reflected in
column (a))
 
  (a)  (b)    
Equity compensation plans approved by security holders  -  $-   - 
             
Equity compensation plans not approved by security holders  196,000,000   n/a   114,000,000 
Total  196,000,000   -   114,000,000 

Recent Sales of Unregistered Securities

None

 

During the three months ended June 30, 2020, the Company issued 200,989,838 shares of common stock upon conversion of $249,545 in principal of convertible notes, plus accrued interest of $49,200, and other fees of $1,900.

11


 

During the three months ended June 30, 2020, the Company issued 16,313,820 shares of common stock for services.

In connection with the foregoing, the Company relied on an exemption from registration provided under Section 4(a)(2) of the Securities Act of 1933, as amended for transactions not involving a public offering.

Issuer Purchases of Equity Securities

None.

Item 6. Selected Financial Data[Reserved.]

Not required for a smaller reporting company.

Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations.

Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” below, and elsewhere in this annual report, are not related to historical results, and are forward-looking statements.

Forward-looking statements present our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements frequently are accompanied by such words such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” or the negative of such terms or other words and terms of similar meaning. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements, or timeliness of such results. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. We aredisclaim any obligation to publicly update these statements, or disclose any difference between actual results and those reflected in these statements, except as may be required under no duty to update any of the forward-looking statements after the date of this annual report. applicable law

Subsequent written and oral forward looking statements attributable to us or to persons acting in our behalf are expressly qualified in their entirety by the cautionary statements and risk factors set forth below and elsewhere in this annual report, and in other reports filed by us with the SEC.

You should read the following description of our financial condition and results of operations in conjunction with the financial statements and accompanying notes included in this Annual Report beginning on page F-1.

Overview

At SunHydrogen Inc., our goal is developing breakthrough technologies to replace most forms of energy on earth with clean renewable hydrogen.

make, store and use green hydrogen in a market that Goldman Sachs estimates to be worth $12 trillion by 2050. Our patented low-costSunHydrogen Panel technology, is intended to produce renewable hydrogen usingcurrently in development, uses sunlight and any source of water including seawater and wastewater. Unlike non-renewable hydrocarbon fuels, such as oil, coal and natural gas, where carbon dioxide and other contaminants are released into the atmosphere when used, hydrogen fuel usage produces pure water as the only byproduct. By optimizing the science of water electrolysis at the nano-level, our low-cost nanoparticles mimic photosynthesis to efficiently use sunlight to split water molecules into environmentally friendly renewable hydrogen. Using our low-cost method to produce renewablelow-cost green hydrogen. Similar to solar panels that produce electricity, our SunHydrogen Panels will produce green hydrogen. Our vision is to become a major technology supplier in the new hydrogen economy. By developing, acquiring and partnering with other critical technologies, we intend to enable a worldfuture of distributed hydrogen production for renewable electricityemission-free vehicles, ships, data centers, aircrafts and hydrogen fuel cell vehicles.more.

Our technology is primarily developed at the University of Iowa, through a sponsored research agreement. Over the past several years, our team has been focused on developing the technology to a point at which it can be commercialized. After years of dedication, we are now ready to move from the lab into commercial production with the first generation of our technology.

Our innovative technology is packaged into a self-contained hydrogen production panel that requires only sunlight and any source of water. Just like solar panels convert sunlight into electricity, our hydrogen panels will convert sunlight and water into hydrogen. As a result of this form factor, the panels can be installed almost anywhere to produce hydrogen fuel at or near the point of use. We believe that this distributed model of hydrogen production addresses one of the biggest challenges of the hydrogen economy, which is the prohibitive high infrastructure cost of transporting hydrogen to the points of use.

Results of Operations for the Year Ended June 30, 20202023 compared to the Year Ended June 30, 2019.2022

Operating Expenses

For the year ended June 30, 20202023, operating expenses were $1,681,427$9,267,147, compared to $1,828,551$4,475,225 for the prior year ended June 30, 2019.2022. Operating expenses consist primarily of research and development expenses and general and administrative expenses incurred in connection with the operation of our business. The net decreaseincrease of $147,124$4,791,922 in operating expenses was a result of a decrease in general and administrative expense of $235,375, which consist of $261,919 in non-cash stock compensation expense, with an increase in salaries of $26,544 in other general and administrative expense and$2,706,923, an increase in research and development cost of $86,820, and$1,647,649, an increase in depreciationprofessional fees of $174,427, with a decrease in marketing of $240,859, an increase in non-cash stock compensation of $331,547, and amortization expensean overall increase of $1,431.

$171,735.

12

Other Income/(Expenses)

Other income and (expenses) for the year ended June 30, 20202023, were $(55,847,911)$10,242,126 compared to $5,806,888$94,506,158 for the prior year ended June 30, 2019.2022. The net increasemajority of $(61,654,799)the decrease of $84,264,033 in other income and (expenses) was the result of the increase in net change in derivative liability.derivatives of $86,796,839, a decrease in loss on redemption of marketable securities of $76,792, an increase in dividend expense of $19,075, an increase in investment income of $909,906, an increase in realized loss on sale of investment of $3,735, a decrease in loss on settlement of debt of $1,793, an increase in unrealized gain on investments in affiliate of $655,601, with a decrease in interest expense of $466,391.


 

Net Income (Loss)

For the year ended June 30, 20202023, our net loss ofincome was $(57,529,338),$974,979, compared to a net income of $3,978,337$90,030,933, for the year ended June 30, 2019. 2022. The majority of the increasedecrease in net lossincome of $61,507,675,$89,055,954, was related primarily to the net change in derivative estimates each year. These estimates arewere based on multiple inputs, includingthe exchange of the convertible notes to Series C Preferred Shares, the market price of our stock, interest rates, our stock price, volatility, variable conversion prices based on market prices defined in the respective agreements and probabilities of certain outcomes based on managements’ estimates. These inputs are subject to significant changes from period to period, therefore, the estimated fair value of the derivative liabilities will fluctuate fromwere removed during the period due to period, and the fluctuation may be material.exchange for preferred shares. The Company has not generated any revenues.

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures. 

As of June 30, 2020,2023, we had a working capital deficitsurplus of $60,459,862,$47,689,381, compared to a working capital deficitsurplus of $4,829,162$24,865,577 as of June 30, 2019.2022. This increase in working capital deficitsurplus of $55,630,700$22,823,804 was primarily due to the increase in net change incash received through sales of our common stock, investments, as well as the non-cash removal of the derivative liability, cash, accounts payable, accrued expenses, accrued interest on convertible notes, with a decrease in prepaid expenses, and convertible notes.liability.

 

During the year ended June 30, 2020,2023, we raised an aggregate of $856,500$2,733,494 from sales of our common stock in a private placement of convertible notes.registered direct offering. During the prior year ended June 30, 2019,2022, we raised an aggregate of $804,500$960,000 from sales of our common stock in a private placement of convertible notes. Our ability to continue as a going concern is dependent upon our ability to raise capital and future revenue generated from operations.registered direct offerings.

Cash flow used in operating activities was $695,784$4,262,085 for the year ended June 30, 2020,2023, compared to $853,693$3,435,038 for the year ended June 30, 2019.2022. The decreaseincrease of $826,047 in cash used by operating activities was primarily due to thea decrease in insurance expense.convertible debt for the exchange to preferred shares, non-cash stock compensation expense, and the removal of non-cash derivative liabilities. The Company has had no revenues.

Cash used inprovided by investing activities for the year ended June 30, 20202023 was $11,101,386, and 2019cash used by investing activities as of the prior period ended June 30, 2022 was $780 and $13,059, respectively.$24,400,032. The decreaseincrease of $35,501,418 in cash provided by investing activities was as a result of a decreasethe net redemption and purchase of marketable securities of $45,535,232, and the purchase of investment in intangible assets purchased duringaffiliate of $7,000,000 and the current year.purchase of long term convertible note, affiliate of $3,000,000, and the purchase of equipment in the amount of $33,814.

Cash provided by financing activities during the year ended June 30, 20202023 was $856,500$2,665,203, compared to $804,500 for the prior year ended June 30, 2019. The increase in cash fromused by financing activities was due to the increase in issuance of convertible notes through private placement offerings during the current period.

During the year ended June 30, 2020, we did not generate any revenue but incurred net loss of $57,529,338 and used cash in the amount of $695,784 in our operations. As of June 30, 2020, we had a working capital deficiency of $60,459,862 and a shareholders’ deficit of $61,832,448. These factors, among others raise substantial doubt about our ability to continue as a going concern. Our independent auditors, in their report dated September 23, 2020, on our audited financial statements$(490,000) for the year ended June 30, 2020 expressed substantial doubt about2022. The increase in cash provided by financing activities was due to an increase in cash provided through sales of our ability to continue as a going concern. Our ability s to continue as a going concern and appropriateness of using the going concern basis is dependent on our ability to generate a profit which is dependent upon our ability to obtain additional equity or debt financing, advance our technology and, ultimately, to achieve profitable operations.common stock.

We have historically obtained funding from our shareholders,investors, through private placementplacements and registered offerings of equity and debt securities. Management believes that itthe Company will be able to continue to raise funds through the sale of its securities to its existing shareholders and prospective new investors which will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the Company to continue to develop its core business. There can be no assurance that we will be able to continue raising the required capital for our operations and if available, on terms and conditions that are acceptable.acceptable to us, or at all. If we are unable to obtain sufficient funds, we may be forced to curtail and/or cease the development of our technology.

operation.

13

Off-Balance Sheet Arrangements 

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues or expenses, result of operations, liquidity or capital expenditures.


 

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to impairment of property, plant and equipment, intangible assets, deferred tax assets and fair value computation using the Binomial lattice valuation pricing model. We base our estimates on historical experience and on various other assumptions, such as the trading value of our common stock and estimated future undiscounted cash flows, that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

Use of Estimates

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to recording, useful lives and impairment of tangible and intangible assets, derivatives, accruals, income taxes, stock-based compensation expense, binomial model inputs and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

Fair Value of Financial Instruments

Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2020,2023 and 2022, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

Recently Adopted Accounting Pronouncements

Management adopted recently issued accounting pronouncements during the year ended June 30, 2020,2023, as disclosed in the Notes to the financial statements included in this report.

Item 7A. Quantitative and Qualitative Disclosure About Market Risk.

Not required for a smaller reporting company.

Item 8. Financial Statements.

All financial information required by this Item is attached hereto at the end of this report beginning on page F-1 and is hereby incorporated by reference.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

 

None.


Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. 

Our management, with the participation of our CEO and our Acting CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our CEO and our Acting CFO concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective to ensure that information required to be disclosed is made known to management and others, as appropriate, to allow timely decision regarding required disclosure and that the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (ii) accumulated and communicated to our management, including our CEO and Acting CFO, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

14

Management’s Annual Report on Internal Control over Financial Reporting.

We are responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of June 30, 20202023 based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013). Based on this evaluation, management concluded that our internal control over financial reporting was effective as of June 30, 2020,2023, based on those criteria.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permanently exempt smaller reporting companiescompanies.

Changes in Internal Controls.

There has been no change in our internal control over financial reporting that occurred during the last fiscal quarter of fiscal year ended June 30, 20202023 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

Item 9B. Other Information.

None.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 

Not applicable.

 

None.

15

 

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

The following table sets forth information about our executive officers key employees and directors:

Name Age Position
Timothy Young 5558 President, CEO, Acting CFO and Chairman of the Board of Directors
Mark J. Richardson 6770 Director
Woosuk Kim58Chief Operating Officer and Director

Timothy Young – President, CEO, Acting CFO and Chairman of the Board of Directors

Tim Young is an accomplished executive with over fifteen years of management experience in media and Internet technology companies. Mr. Young was appointed President, CEO and Chairman of the Company in August 2009.2009. Mr. Young was appointed Acting CFO in 2010.

Through his outreach to the public and to leaders in the renewable energy field, Mr. Young overseeshas bolstered the Company’s researchcompany’s visibility as a key player in the developing green hydrogen market and development initiativesrallied a strong investor base. Mr. Young’s proven fundraising ability, along with his leadership and fundraising efforts.direction of SunHydrogen’s long-term and short-term goals and strategies, has enabled the company to engage international industrial partners, attract top industry scientists, and most importantly continue to hit milestones toward commercializing its nanoparticle-based green hydrogen technology.

From September 2007 through August 2009, Prior to founding SunHydrogen, Mr. Young demonstrated a track record of success in management and leadership positions bringing new products to the market in the digital, cable and broadcast media industries. Mr. Young was the President of Rovion, Inc., an internet media startupa digital advertising company, where he increased revenues through a channel sales strategy that included companies such as Clear Channel, Disney, CBS, and Fox Television and bolstered the company’s technical capabilities through strategic acquisitions.

Prior to Rovion, Mr. Young was employed byenjoyed a decade-long career at Time Warner Inc. from October 1998 through July 2007, where he served as Vice President and Regional Vice President of various divisions including America Online and Time Warner Cable. During his tenure, Mr. Young built some of the highest performing sales organizations at Time Warner with responsibilities ranging from product development and marketing to staff training and leadership development. He led the California and Hawaii sales teams which accounted for over $200 million in revenues with 250 sales and marketing personnel.

Mr. Young’s track record of success and over fifteen plus years of management and leadership experience bringing new products to the market qualifies him to be a board member of the Company.

Mark J. Richardson –Director– Director

Mr. Richardson was appointed as a director in June 2018. Mr. Richardson has been a securities lawyer since he graduated from the University of Michigan Law School in 1978. He practiced as an associate and partner in large law firms until 1993, when he established his own practice under the name Richardson & Associates. He has been the principal securities counsel on a variety of equity and debt placements for corporations, partnerships, and real estate companies. His practice includes public and private offerings, venture capital placements, debt restructuring, compliance with federal and state securities laws, representation of publicly traded companies, Nasdaq filings, corporate law, partnerships, joint ventures, mergers, asset acquisitions, and stock purchase agreements. As a partner in a major international law firm in the 1980’s, Mr. Richardson participated in the leveraged buyout and recapitalization of a well-known producer of animated programming for children, financed by Prudential Insurance and Bear Stearns, Inc. He was also instrumental in restructuring the public debentures of a real estate company without resorting to a bankruptcy proceeding. From 1986 to 1993 Mr. Richardson was a contributing author to State Limited Partnerships Laws – California Practice Guide, Prentice Hall Law and Business. Prior to receiving his Juris Doctor degree cum laude from the University of Michigan Law School in 1978, Mr. Richardson received a Bachelor of Science degree summa cum laude in Resource Economics from the University of Michigan School of Natural Resources in 1975, where he earned the Bankstrom Prize for academic excellence and achieved Phi Beta Kappa honors. Mr. Richardson is an active member of the Los Angeles County and California State Bar Associations, including the Section on Corporations, Business and Finance and the Section on Real Estate.

The Board has determined that Mr. Richardson is qualified to serve as a director because of his extensive experience as a practicing attorney representing small companies.

16


 

Woosuk Kim – Chief Operating Officer and Director

Woosuk Kim has served as our chief operating officer and director since April 1, 2021. From May 2011 to December 2019, Mr. Kim was senior vice president, head of M&A group at SK Innovation in Seoul, South Korea, responsible for expanding core businesses and developing new business opportunities in the renewable energy sector through cross border acquisitions and joint venture transactions. From August 2009 to May 2011 Mr. Kim was vice president, corporate development at SK Telekom. From August 2006 to March 2008, Mr. Kim was chief financial officer at Axon Financial Services in New York. From July 1998 to August 2006, Mr. Kim was executive director at Morgan Stanley in New York, responsible for developing and operating multi-billion dollar asset-backed securities funding platforms, investor marketing, and the corporate treasury function for Discover Card. He received an MBA from Cornell University and a BA from the University of Chicago.

Mr. Kim’s financial industry knowledge and experience qualify him to serve on our board of directors.

Directors are elected at our annual meeting of shareholders and serve for one year until the next annual meeting of shareholders or until their successors are elected and qualified.

Family Relationships

There are no family relationships among our executive officers and directors.

Board Leadership Structure and Role in Risk Oversight

Although we have not adopted a formal policy on whether the Chairman and Chief Executive Officer positions should be separate or combined, we have traditionally determined that it is in the best interests of the Company and its shareholders to combine these roles. Currently, we have only one executive officer, who is our Chief Executive Officer who also serves as Chairman of the Board. Due to the small size and early stage of the Company, we believe it is currently most effective to have the Chairman and Chief Executive Officer positions combined.

Involvement in Certain Legal Proceedings

During the past ten years, none of our directors, executive officers, promoters, control persons, or nominees has been:

the subject of any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;

convicted in a criminal proceeding or is subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or any Federal or State authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;

found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law.

the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of (a) any Federal or State securities or commodities law or regulation; (b) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or (c) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.


 

Committees of the Board

Due to the small size of the Company and its Board of Directors, we currently have no audit committee, compensation committee or nominations and governance committee of our board of directors. We do not have an audit committee financial expert.

Code of Ethics

We have adopted a Code of Ethics that applies to all of our directors, officers and employees. A copy of the Code of Ethics can be obtained without charge upon request to Timothy Young, CEO and President, 10 E. Yanonali, Suite 36, Santa Barbara, CA 93101BioVentures Center, 2500 Crosspark Road, Coralville, IA 52241 and is also being incorporated by reference herein. Any waiver of the provisions of the Code of Ethics for executive officers and directors may be made only by the Board of Directors. Any such waivers will be promptly disclosed to our shareholders.

Changes in Nominating Procedures

None.

Item 11. Executive Compensation

The table below sets forth the compensation earned by each person acting as our Principal Executive Officer and our other most highly compensatednamed executive officers whose total annual compensation exceeded $100,000 during the last two fiscal years.

Name & Principal Position Year  Salary ($)  Bonus ($)  Stock Awards ($)  Option Awards ($)  Non Equity Incentive Plan Compensation ($)  Non-Qualified Deferred Compensation Earnings
($)
  All Other Compensation ($)  Total
($)
 
Timothy Young, 2023  $354,000  $354,000  $2,700,000(1)        -           -           -          -  $3,408,000 
CEO and Acting CFO 2022  $340,385  $354,000   -   -   -   -   -  $694,385 
                                    
Woosuk Kim 2023  $275,000  $206,250  $1,350,000(1)  -   -   -   -  $1,831,250 
COO 2022  $264,423  $206,250   -   -   -   -   -  $470,673 

(1)Mr. Young and Mr. Kim were awarded restricted stock on November 8, 2022.

17


 

Name & Principal Position Year  Salary
($)
  Bonus
($)
  Stock
Awards
($)
  Option Awards
($)
  Non-Equity Incentive Plan Compensation ($)  Non-Qualified Deferred Compensation Earnings
($)
  All Other Compensation ($)  Total
($)
 
Timothy Young,  2020  $255,000             0     0   

757,243

            0       0           0  $255,000 
CEO and Acting CFO  2019  $255,000   0   0   1,409,550(1)   0   0   0  $255,000 

(1)Calculated at fair value in accordance with authoritative guidance provided by the Financial Accounting Standards Board, where the value of the stock compensation is based upon the grant date and recognized over the vesting period. On the grant date of January 23, 2019, one-third (1/3) of the options vested immediately and the remainder of the options will vest in increments of 1/24 monthly. The shares represent an option to purchase 150,000,000 shares of common stock at an exercise price of $0.0099, with a fair value of $757,243. As of June 30, 2020, no options were exercised.

Employment Agreements

Our CEO, Timothy Young is employed as an “at-will” employee whose employment with the Company may be terminated at any time by either party. We have agreed to pay Mr. Young an annual salary of $255,000, subject to modification in accordance with the Company’s policies, practices and procedures.  In addition, we have agreed to pay Mr. Young three months base salary, in the event his employment is terminated by the Company. Mr. Young is eligible to receive a quarterly bonus as determined by the Company’s Board of Directors and to participate in any benefit plan implemented by the Company. 

Outstanding Equity Awards at Fiscal Year-End

The following table discloses information regarding outstanding equity awards granted or accrued as of June 30, 2020,2023, for our named executive officer.officers.

Outstanding Equity Awards
  Option Awards  Stock Awards 
Name Number of
Securities
Underlying
Unexercised (#)
Exercisable
  Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
   Option
Exercise
Price ($)
  Option
Expiration
Date
  Number of
Shares or Units
of Stock that
have not
Vested (#)
  Market Value of
Shares or Units
of Stock that
have not
Vested ($)
 
Timothy Young 121,780,822  28,219,178   0.0099  1/23/2029  -  - 
Outstanding Equity Awards
   Option Awards  Stock Awards 
Name  Number of
Securities
Underlying
Unexercised (#)
Exercisable
   Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
   Option
Exercise
Price ($)
  Option
Expiration
Date
  Number of
Shares or Units of
Stock that
have not
Vested (#)
   Market
Value of
Shares or Units of
Stock that
have not
Vested ($)
 
Timothy Young  125,812,947   -   .0099  1/23/2026  -   - 
Woosuk Kim  -   -   -  -  -   - 

Director Compensation

The following table sets forth compensation information regarding the Company’s non-employee directors in fiscal 2020:2023:

Name Fees earned or
paid in cash
  Stock
Award
($)
  Option
Awards
($)
  Non-equity
incentive
plan
compensation
  Nonqualified
deferred
compensation
earnings
  Non-Equity
Incentive Plan
Compensation
($)
  Non-Qualified
Deferred
Compensation
Earnings
($)
  All Other
Compensation ($)
  Total
($)
 
Mark R. Richardson $42,000  $75,000         -           -           -          -          -            -  $117,000 

 

Name 

Fees earned or paid in cash 

  

Stock Award

($)

  Option Awards ($)  Non-equity incentive plan compensation  Nonqualified deferred compensation earnings  Non-Equity Incentive Plan Compensation ($)  Non-Qualified Deferred Compensation Earnings
($)
  

All Other Compensation

($)

  Total
($)
 
Mark R.  Richardson            1            -  $10,000,000             -          -            -            -                -   10,000,000 


Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The following table sets forth certain information, as of September 28, 2023, concerning the number of shares of our common stock owned by: (i) each of our directors; (ii) each of our named executive officers; and (iii) each person or group known by us to beneficially own more than 5% of our outstanding shares of common stock.  

 

We believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them.

 

A person is deemed to be the beneficial owner of securities that can be acquired by him within 60 days from the date of this reportSeptember 28, 2023, upon the exercise or conversion of options, warrants or convertible securities. Each beneficial owner’s percentage ownership is determined by assuming that options, warrants or convertible securities that are held by him, but not those held by any other person, and which are exercisable within 60 days of September 18, 202030, 2023 or have been exercised and converted.

18

 

Name and address Shares of Common Stock  Percentage of Common Stock (1) 
       
Directors and Officers (2)      
Timothy A. Young  147,500,000(3)  6.4 
Mark R. Richardson  9,166,667(4)  * 
All Officers and Directors as a Group (2 person)  156,666,667   6.8%
  Shares
Held
  Unexercised
Stock
Options
  Total  Percentage of
Common Stock
 
Timothy A. Young  70,500,000   125,812,947   193,312,947   3.9 
Mark R. Richardson  3,000,000   3,081,552   6,081,552   * 
Woosuk Kim  24,950,000   -   24,950,000   * 
All officers and directors as a group (3 persons)  90,450,000   128,894,499   227,344,499     

 

* Less than 1%.

(1)*Less than 1%

(1)Based upon 2,156,132,1555,061,034,972 shares issued and outstanding as of September  18, 2020.28, 2023.

 

(2)(2)The address for each of the officers and directors is c/o SunHydrogen, Inc. 10 E. Yanonali, Suite 36, Santa Barbara, CA 93101
(3)Includes 137,500,000 shares underlying options that have vested or will vest within sixty days of this annual report.
(4)Represents shares underlying options that have vested and will vest within sixty days of this annual report.BioVentures Center, 2500 Crosspark Road, Coralville, IA 52241

Securities authorized for issuance under equity compensation plans

On January 23, 2019, our Board adopted the Company’s 2019 Equity Incentive Plan (the “2019 Plan”). The stated purpose of the 2019 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The maximum number of shares of the Company’s common stock that can be issued under the Plan is 300,000,000. The Plan has been approved by stockholders.

On January 27, 2022, our Board adopted the Company’s 2022 Equity Incentive Plan (the “2022 Plan”). The stated purpose of the 2022 Plan is to attract and retain the types of employees, consultants, and directors who will contribute to the Company’s long-range success. The maximum number of shares of the Company’s common stock that can be issued under the 2022 Plan is initially 400,000,000. The number of shares will automatically be increased on the first day of the Company’s fiscal year beginning in 2023 so that the total number of shares issuable will at all times equal fifteen percent (15%) of the Company’s fully diluted capitalization on the first day of the Company’s fiscal year, unless the Board adopts a resolution providing that the number of shares issuable under the 2022 Plan shall not be so increased.

The following table sets forth information about our equity compensation plans as of June 30, 2023.

Plan Category Number of
securities to
be issued
upon
exercise of
outstanding
options,
warrants
and rights
  Weighted-
average
exercise
prices of
outstanding
options,
warrants
and rights
  Number of
securities
remaining
available for
future
issuance
under the
equity
compensation
plans
(excluding
securities
reflected in
column (a))
 
  (a)  (b)    
2019 Equity compensation plan approved by security holders  286,770,561  $0.0099-$0.016   13,229,439 
2022 Equity compensation plan approved by security holders  120,600,000  $0.025-$0.035   279,600,000 
Total  407,370,561      292,829,439 


Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

Certain Relationships and Related Transactions 

 

SinceAs of June 30, 2023, the beginning of our last fiscal year, except as set forth below, there have been and there are no currently proposed transaction, in which we are or wereCompany owed $143,459 to Timothy Young for a participant and the amount involved exceeds $120,000 or one percent of the average of our total assets at year-endloan payable for the last two completed fiscal years, andpayment of operating expenses in which any director, executive officer, holder of more than 10% of any class of our voting securities, had or will have a direct or indirect material interest.prior periods.

 

On September 10, 2020, the Company entered into rescission agreements with Timothy Young, the Company’s chief executive officer and director, and Mark Richardson, the Company’s director. Under the rescission agreements, the cashless option exercises of Mr. Young and Mr. Richardson that were completed on June 24, 2020, were rescinded and unwound in full. Under Mr. Young’s option exercise, Mr. Young had exercised 50,000,000 options cashlessly at an exercise price of $0.0099 per share and was issued 39,239,130 shares of common stock. Under Mr. Richardson’s option exercise, Mr. Young had exercised 8,055,542 options cashlessly at an exercise price of $0.0099 per share and was issued 6,321,849 shares of common stock.

Director Independence 

 

The Board has determined that Mr. Richardson is an independent director within the meaning of NASDAQ Rule 5605(a)(2).

Item 14. Principal Accountant Fees and Services.

 

Audit Fees

 

The aggregate fees billable to us by our principal accounting firm during 2020the years ended June 30, 2023 and 20192022 for the audit of our annual financial statements and quarterly reviewsreview of our financial statements included in our Form 10-Qs or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for thethose fiscal year totaled years, were approximately $11,000$32,000 and $25,000,$32,000, respectively.

 

Audit-Related Fees

 

We incurred assurance and audit-related fees during 2020 and 2019 of $0 and $0 to our principal accountant in connection with the audit of the financial statements of the Company for the years ended June 30, 20202023 and 2019.2022, respectively, to our principal accountant for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees” above.

 

Tax Fees

 

We did not incur fees for services rendered to us for tax compliance, tax advice, or tax planning by our principal accountant for the fiscal years ended June 30, 20202023 and 2019.2022. 

 

All Other Fees

 

As of the date of this filing, ourOur current policy is to not engage M&K CPAS, PLLC to provide, among other things, bookkeeping services, appraisal or valuation services, or international audit services. The policy provides that we engage M&K CPAS, PLLC to provide audit, and other assurance services, such as review of SEC reports or filings.

 

19

 

 

PART IV

Item 15. Exhibits.Exhibits and Financial Statement Schedules.

 

(1) Financial statements.

The SunHydrogen, Inc. financial statements are included in Item 8. Financial Statements and Supplementary Data.

(2) Financial statement schedules: None.

(3) Exhibits

Exhibit   Description
   
3.1 Articles of Incorporation of filed with the Nevada Secretary of State on February 18, 2009 (incorporated by reference to S-1 filed on February 5, 2010).
   
3.2 Articles of Amendment of Articles of Incorporation filed with the Nevada Secretary of State on September 11, 2009 (incorporated by reference to S-1 filed February 5, 2010).
   
3.3 Articles of Amendment of Articles of Incorporation of filed with the Nevada Secretary of State on November 21, 2013 (incorporated by reference 8-K filed on November 21, 2013).

3.4 Articles of Amendment of Articles of Incorporation filed with the Nevada Secretary of State on September 13, 2018. (incorporated by reference to 10-K filed on September 25, 2018).
   
3.5 Certificate of Designation of Series A Preferred Stock (incorporated by reference to the Company’s Form 8-K filed February 2, 2022)
3.6Certificate of Designation of Series B Preferred Stock (incorporated by reference to the Company’s Form 8-K filed November 26, 2019)
   
3.63.7 Certificate of Designation of Series C Preferred Stock (incorporated by reference to the Company’s Form 8-K filed December 17, 2021)
3.8Certificate of Amendment to Articles of Incorporation (incorporated by reference to 8-K filed January 3, 2020)
   
3.73.9 Articles of Merger (incorporated by reference to 8-K filed June 15, 2020)
   
3.83.10 BylawsCertificate of Amendment to Articles of Incorporation (incorporated by reference to S-1 February 5, 2010)10-Q filed May 16, 2022)
   
10.13.11 Amended and Restated Bylaws (incorporated by reference to 8-K filed February 2, 2022)
4.1Description of Registrant’s Securities
10.12019 Equity Incentive Plan (incorporated by reference to Form S-8 on December 19, 2018)


10.2Form of Placement Agent Warrant (incorporated by reference to 8-K filed December 3, 2020)
   
10.210.3 Contract between Company and the UniversityForm of Iowa dated as of May 1, 2016Warrant (incorporated by reference to 10-K8-K filed on September 21, 2016).February 26, 2021)
   
10.310.4 OfferForm of Employment to Timothy Young dated August 13, 2009Placement Agent Warrant (incorporated by reference to S-18-K filed on March 25, 2010)February 26, 2021)
   
10.410.5 Invention Transfer dated as of June 10, 2009Employment Agreement between the Company and Timothy Young (incorporated by reference Form S-1to 8-K filed on March 25, 2010)1, 2021) ***
   
10.510.6 Convertible Promissory Note dated May 23, 2014Employment Agreement between the Company and Woosuk Kim (incorporated by reference to 10-Q8-K filed on May 15, 2018)April 7, 2021) ***
   
10.610.7 Convertible Promissory NoteContract, dated January 28, 2016 (incorporated by reference Form 10-Q filed on May 15, 2018)
10.7Convertible Promissory Note dated February 3, 2017 (incorporated by reference to Form 10-Q filed on May 15, 2018f)
10.8Convertible Promissory Note dated November 10, 2017 (incorporated by reference to Form 10-Q on May 15, 2018)
10.9Convertible Promissory Note dated July 27, 2018 (incorporated by reference to Form 8-K filed on June 29, 2018)
10.10Convertible Promissory dated July 23, 2018 (incorporated by reference to Form 8-K on August 6, 2018)

10.11Promissory Note issued August 10, 2018 (incorporated by reference to Form 8-K filed on August 14, 2018)
10.12Agreement dated as of JuneOctober 1, 20182022, between the Company and The University of Iowa, Iowa City Iowa (incorporated by reference to Form 10-K filed on September 25, 2018)October 7, 2022)
   
10.1310.8 ConsultingResearch Agreement dated as of September 19, 2018Amendment No. 1 between the Company and GreenTech Development CorporationRegents of the University of Michigan (incorporated by reference to Form 10-K filed on September 25, 2018)October 7, 2022)
10.9Research Agreement Amendment No. 1 between the Company and Regents of the University of Michigan (incorporated by reference to Form 10-K filed October 7, 2022)
   
10.1410.10 Convertible Promissory Note dated October 3, 2018 between the Company and PowerUp LendingSunHydrogen, Inc. 2022 Stock Incentive Plan (incorporated by reference to Form 8-K on10-K filed October 12, 2018)

20

10.15Convertible Promissory Note dated January 18, 2019 (incorporated by reference to Form 10-Q filed on May 14, 2019)7, 2022)
   
10.1614.1 Agreement between the Company and The University of Iowa, Iowa City effective as of June 1, 2019 (incorporated by reference to Form 10-K filed on September 30, 2019)

10.17Contract Amendment No. 1 between the Company and The University of Iowa (incorporated by reference to 8-K filed June 26, 2020)
10.18Purchase Agreement between the Company and Triton Funds LP (incorporated by reference to 8-K filed July 31, 2020)
10.19Contract, dated September 1, 2020, between the Company and The University of Iowa, Iowa City (previously filed)
10.20Purchase Agreement, dated September 21, 2020, between the Company and GHS Investments, LLC (previously filed)
14.1Code of Ethics (incorporated by reference to 10-K filed on September 28, 2012).
   
16.123.1* Letter from Liggett & Webb, P.A. (incorporated by reference to 8-K filed January 7, 2020)Consent of M&K CPAS, LLC
   
23.1*31.1* Consent of Liggett & Webb, P.A.
23.2*Consent of M&K CPAS, LLC
31.1*Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to Sarbanes-Oxley Section 302
   
32.1** Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350

EX-101.INSXBRL INSTANCE DOCUMENT (previously filed)
EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (previously filed)
   
EX-101.CAL101 Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (previously filed)Document Set for the consolidated financial statements and accompanying notes in Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.
   
EX-101.DEF104 Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (previously filed)
EX-101.LABfor the cover page of this Annual Report on Form 10-K, included in the Exhibit 101 Inline XBRL TAXONOMY EXTENSION LABELS LINKBASE (previously filed)
EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (previously filed)Document Set.

 

*Filed herewith.

****Furnished herewith.

 

***Indicates management contract or compensatory plan or arrangement.

Item 16. Form 10-K Summary.

None.

21

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 SUNHYDROGEN, INC.
   
Date:  April 14, 2021September 29, 2023By:/s/ Timothy Young
  

Timothy Young

Chief Executive Officer,
Interim
Acting
Chief Financial Officer, and Chairman (principal
(principal
executive, financial and
accounting officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature Title Date
     
/s/ Timothy Young Chief Executive Officer, President April 14, 2021September 29, 2023
Timothy Young 

(Principal Executive Officer) Acting Chief Financial Officer

(Principal Financial and Accounting Officer), and Chairman

  
     
/s/ Mark R. Richardson Director April 14, 2021September 29, 2023
Mark R. Richardson
/s/ Woosuk KimDirectorSeptember 29, 2023
Woosuk Kim    

 

22


 

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID No. 2738)

 

To the Board of Directors and ShareholdersStockholders

SunHydrogen, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheetsheets of SunHydrogen, Inc. (the Company) as of June 30, 2020,2023 and 2022, and the related statements of operations, shareholders’ deficit,equity (deficit), and cash flows for each of the year thenyears in the two-year period ended June 30, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2020,2023 and 2022, and the results of its operations and its cash flows for each of the year thenyears in the two-year period ended June 30, 2023 in conformity with accounting principles generally accepted in the United States of America. The financial statements of SunHydrogen, Inc. as of June 30, 2019 were audited by other auditors whose report dated September 27, 2019 expressed an unqualified opinion on those financial statements.

 

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered net losses from operations and has a net capital deficiency, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are discussed in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit.audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB .PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and the significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe our audit provides a reasonable basis for our opinion.

/s/ M&K CPAS, PLLC

M&K CPAS, PLLC

We have served as the Company’s auditor since 2020

Houston, TX

September 23, 2020


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of

HyperSolar, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of SunHydrogen, Inc. (formerly HyperSolar, Inc.) (the “Company”) as of June 30, 2019, the related statements of operations, shareholders’ deficit, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2019, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

The Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  As discussed in Note 1 to the financial statements, the Company does not generate revenue and has negative cash flows from operations.  This raises substantial doubt about the Company’s ability to continue as a going concern.  Management’s plans in regard to these matters are also described in Note 1.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditaudits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with the standards of the PCAOB.reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion in accordance with the standards of the PCAOB.opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and the significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Liggett & Webb, P.A.

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

Capital Stock and Other Equity Accounts

As discussed in Note 3, the Company issued preferred stock to third parties in exchange for convertible note principal and accrued interest. Auditing management’s calculation of the fair value of the preferred shares issued can be a significant judgment due to the need of a specialist to evaluate the fair value of the preferred shares issued and the auditor has to test the inputs and estimates used.

Auditing management’s calculation of the fair value of the preferred shares issued can be a significant judgment given the fact that the Company uses management estimates on various inputs to the calculations.

We evaluated management’s conclusions regarding their fair values and reviewed support for the significant inputs used in the valuation model, as well as assessing the model for reasonableness. In addition, we evaluated the Company’s disclosure in relation to this matter included in Notes 3 to the financial statements.

/s/ M&K CPAS, PLLC

M&K CPAS, PLLC

We have served as the Company’s auditor since 2014.2020

 

New York, NYHouston, TX

September 27, 201929, 2023


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)


BALANCE SHEETS

 

  June 30,
2020
  June 30,
2019
 
       
ASSETS      
       
CURRENT ASSETS      
Cash $195,010  $35,074 
Prepaid expenses  9,378   15,000 
         
TOTAL CURRENT ASSETS  204,388   50,074 
         
PROPERTY & EQUIPMENT        
Computers and peripherals  2,663   1,883 
Less: accumulated depreciation  (1,605)  (837)
         
NET PROPERTY AND EQUIPMENT  1,058   1,046 
         
OTHER ASSETS        
Domain, net of amortization of $4,223 and $3,868, respectively  1,092   1,447 
Trademark, net of amortization of $371 and $257, respectively  772   886 
Patents, net of amortization of $16,650  and $10,391, respectively  84,492   97,100 
         
TOTAL OTHER ASSETS  86,356   99,433 
         
TOTAL ASSETS $291,802  $150,553 
         
LIABILITIES AND SHAREHOLDERS’ DEFICIT        
         
CURRENT LIABILITIES        
Accounts payable and other payable $201,243  $125,085 
Accrued expenses  211,496   176,790 
Accrued interest on convertible notes  432,866   415,537 
Derivative liability  59,657,719   3,905,721 
Convertible promissory notes, net of debt discount of $409,074 and $281,783, respectively  160,926   256,103 
         
TOTAL CURRENT LIABILITIES  60,664,250   4,879,236 
         
LONG TERM LIABILITIES        
Convertible promissory notes, net of debt discount of $0 and $0, respectively  1,460,000   1,782,600 
         
TOTAL LONG TERM LIABILITIES  1,460,000   1,782,600 
         
TOTAL LIABILITIES  62,124,250   6,661,836 
         
COMMIMENTS AND CONTINGENCIES (SEE NOTE 8)  -   - 
         
SHAREHOLDERS’ DEFICIT        
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding  -   - 
Common Stock, $0.001 par value; 5,000,000,000 authorized common shares 2,053,410,164 and 1,077,319,339 shares issued and outstanding, respectively  2,053,410   1,077,319 
Additional Paid in Capital  11,664,657   10,432,575 
Accumulated deficit  (75,550,515)  (18,021,177)
         
TOTAL SHAREHOLDERS’ DEFICIT  (61,832,448)  (6,511,283)
         
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT $

291,802

  $

196,572

 
  June 30,
2023
  June 30,
2022
 
ASSETS      
CURRENT ASSETS      
Cash and cash equivalent $37,185,989  $27,681,485 
Marketable securities at cost  3,188,040   24,323,240 
Short term investment at fair value, related party  7,655,601   - 
Prepaid expense  -   2,526 
Other receivable  -   14,868 
TOTAL CURRENT ASSETS  48,029,630   52,022,119 
         
OTHER ASSETS        
BOND RECEIVABLE        
Bond receivable, related party  3,000,000   - 
TOTAL BOND RECEIVABLE  3,000,000   - 
PROPERTY & EQUIPMENT        
Machinery and equipment  33,814   - 
Computers and peripherals  11,529   11,529 
Vehicle  155,000   155,000 
   200,343   166,529 
Less: accumulated depreciation  (83,468)  (46,933)
NET PROPERTY AND EQUIPMENT  116,875   119,596 
INTANGIBLE ASSETS        
Domain, net of amortization of $5,315 and $4,931, respectively  29   384 
Trademark, net of amortization of $714 and $601, respectively  428   542 
Patents, net of amortization of $36,344  and $29,779, respectively  64,799   71,364 
TOTAL INTANGIBLE ASSETS  65,256   72,290 
TOTAL OTHER ASSETS  3,182,131   191,886 
         
TOTAL ASSETS $51,211,761  $52,214,005 
         
LIABILITIES, PREFERRED STOCK SUBJECT TO REDEMPTION AND SHAREHOLDERS’ DEFICIT        
CURRENT LIABILITIES        
Accounts payable and other payables $232,893  $57,390 
Accrued expenses  628   3,070 
Accrued expenses, related party  -   211,750 
Accrued interest on convertible notes  -   191,763 
Derivative liabilities  -   26,015,069 
Loan payable, related party  106,728   - 
Convertible promissory notes  -   677,500 
TOTAL CURRENT LIABILITIES  340,249   27,156,542 
LONG TERM LIABILITIES        
Loan payable, related party  36,731   - 
Convertible promissory notes  -   150,000 
TOTAL LONG TERM LIABILITIES  36,731   150,000 
TOTAL LIABILITIES  376,980   27,306,542 
         
COMMIMENTS AND CONTINGENCIES (SEE NOTE 9)        
Series C 10% Preferred Stock, 10,951 and 2,700 shares issued and outstanding, redeemable value of $1,095,100 and $270,000, respectively  1,095,100   270,000 
         
SHAREHOLDERS’ EQUITY        
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares outstanding  -   - 
Common Stock, $0.001 par value; 10,000,000,000 authorized common shares 4,821,298,283 and 4,271,749,146 shares issued and outstanding, respectively  4,821,298   4,271,749 
Additional Paid in Capital  126,889,423   103,311,733 
Accumulated deficit  (81,971,040)  (82,946,019)
TOTAL SHAREHOLDERS’ EQUITY  49,739,681   24,637,463 
         
TOTAL LIABILITIES, PREFERRED STOCK SUBJECT TO REDEEMPTION AND SHAREHOLDERS’ EQUITY $51,211,761  $52,214,005 

The accompanying notes are an integral part of these financial statements


 

SUNHYDROGEN, INC.
STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED JUNE 30, 2023 AND 2022

  Years Ended 
  June 30,
2023
  June 30,
2022
 
       
REVENUE $-  $- 
         
OPERATING EXPENSES        
Selling and Marketing  131,745   372,604 
General and administrative expenses  5,651,728   2,267,270 
Research and development cost  3,440,106   1,792,457 
Depreciation and amortization  43,568   42,894 
TOTAL OPERATING EXPENSES  9,267,147   4,475,225 
         
LOSS FROM OPERATIONS BEFORE  OTHER INCOME (EXPENSES)  (9,267,147)  (4,475,225)
         
OTHER INCOME/(EXPENSES)        
Investment  income  1,149,859   239,953 
Dividend expense  (27,000)  (7,925)
Unrealized Gain(loss) on investments, related party  655,601   - 
Realized gain(loss)  (3,735)  - 
Loss on settlement of debt  (42)  (1,835)
Loss on redemption of marketable securities  -   (76,792)
Gain(Loss) on settlement of derivative liability  (664,627)  (1,109,761)
Gain on change in derivative liability  9,204,387   96,001,226 
Interest expense  (72,317)  (538,708)
TOTAL OTHER INCOME (EXPENSES)  10,242,126   94,506,158 
         
NET INCOME $974,979  $90,030,933 
         
BASIC EARNINGS (LOSS) PER SHARE $0.00  $0.02 
         
DILUTED EARNINGS (LOSS) PER SHARE $0.00  $0.02 
         
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING        
BASIC  4,492,448,483   4,103,301,026 
         
DILUTED  4,787,349,172   5,217,576,101 

The accompanying notes are an integral part of these audited financial statements

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)


STATEMENTS OF OPERATIONS

SHAREHOLDERS’ EQUITY/(DEFICIT)
FOR THE YEARS ENDED JUNE 30, 20202023 AND 20192022

 

  Years Ended 
  June 30,
2020
  June 30,
2019
 
       
REVENUE $-  $- 
         
OPERATING EXPENSES        
General and administrative expenses  1,057,287   1,292,662 
Research and development cost  615,721   528,901 
Depreciation and amortization  8,419   6,988 
         
TOTAL OPERATING EXPENSES  1,681,427   1,828,551 
         
LOSS FROM OPERATIONS BEFORE  OTHER INCOME (EXPENSES)  (1,681,427)  (1,828,551)
         
OTHER INCOME/(EXPENSES)        
Loss on write-off of patent cost  (5,426)  - 
Gain (Loss) on change in derivative liability  (54,910,562)  6,641,761 
Interest expense  (931,923)  (834,873)
         
TOTAL OTHER INCOME (EXPENSES)  (55,847,911)  5,806,888 
         
NET INCOME (LOSS) $(57,529,338) $3,978,337 
         
BASIC AND DILUTED LOSS PER SHARE $(0.04) $0.00 
         
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING        
BASIC  AND DILUTED  1,551,749,054   924,582,860 
  YEARS ENDED JUNE 30, 2023 AND 2022 
                 Additional       
  Preferred stock     Common stock  Paid-in  Accumulated    
  Shares  Amount  Mezzanine  Shares  Amount  Capital  Deficit  Total 
Balance at June 30, 2021      -  $      -  $      -   3,849,308,495  $3,849,308  $88,560,321  $(172,976,952) $(80,567,323)
Issuance of common stock for cash  -   -   -   40,983,607   40,984   919,016   -   960,000 
Issuance of common stock for conversion of debt and accrued interest  -   -   -   381,457,044   381,457   (19,073)  -   362,384 
Issuance of Series C preferred stock in exchange for fair value of convertible note  -   -   270,000   -   -   14,340,769   -   14,340,769 
Redemption of related parties stock options  -   -   -   -   -   (1,450,000)  -   (1,450,000)
Stock compensation  -   -   -   -   -   960,700   -   960,700 
Net Income  -   -   -   -   -   -   90,030,933   90,030,933 
Balance at June 30, 2022  -  $-  $270,000   4,271,749,146  $4,271,749  $103,311,733  $(82,946,019) $24,637,463 
Issuance of common stock for conversion of debt and accrued interest  -   -   -   274,198,530   274,199   (13,710)  -   260,489 
Issuance of common stock through a purchase agreement for cash  -   -   -   141,316,755   141,316   2,592,178   -   2,733,494 
Issuance of common stock for theconversion of stock options  -   -   -   1,933,852   1,934   30,941   -   32,875 
Issuance of common stock for restricted stock awards  -   -   -   44,500,000   44,500   1,068,000   -   1,112,500 
Issuance of common stock for conversion of restricted stock awards  -   -   -   87,600,000   87,600   (87,600)  -   - 
Issuance of Series C preferred stock in exchange for fair value of convertible notes  -   -   825,100   -   -   17,475,309   -   17,475,309 
Stock compensation expense for conversion of restricted stock awards  -   -   -   -   -   2,365,200   -   2,365,200 
Stock compensation expense  -   -   -   -   -   147,372   -   

147,372

 
Net income  -   -   -   -   -   -   974,979   974,979 
Balance at June 30, 2023  -  $-  $1,095,100   4,821,298,283  $4,821,298  $126,889,423  $(81,971,040) $49,739,681 

 

The accompanying notes are an integral part of these audited financial statements

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)


STATEMENTS OF SHAREHOLDERS’ DEFICIT

CASH FLOWS
FOR THE YEARS ENDED JUNE 30, 20202023 AND 20192022

  YEAR ENDED JUNE 30, 2019 
              Additional       
  Preferred stock  Common stock  Paid-in  Accumulated    
  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
Balance at June 30, 2018         -  $      -   852,458,018  $852,458  $8,131,620  $(21,999,514) $(13,015,436)
                             
Issuance of common stock for conversion of debt and accrued interest  -   -   195,464,064   195,464   1,345,145   -   1,540,609 
                             
Issuance of common stock for services  -   -   29,397,257   29,397   220,038   -   249,435 
                             
Stock based compensation expense  -   -   -   -   735,772   -   735,772 
                             
Net Income  -   -   -   -   -   3,978,337   3,978,337 
                             
Balance at June 30, 2019  -  $-   1,077,319,339  $1,077,319  $10,432,575  $(18,021,177) $(6,511,283)
                             
  YEAR ENDED JUNE 30, 2020 
              Additional       
  Preferred stock  Common stock  Paid-in  Accumulated    
  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
Balance at June 30, 2019  -  $-   1,077,319,339  $1,077,319  $10,432,575  $(18,021,177) $(6,511,283)
                             
Issuance of common stock for conversion of debt and accrued interest  -   -   884,989,722   884,990   492,196   -   1,377,186 
                             
Issuance of common stock for services  -   -   91,101,103   91,101   266,033   -   357,134 
                             
Stock based compensation expense  -   -   -   -   473,853   -   473,853 
                             
Net Loss  -   -   -   -   -   (57,529,338)  (57,529,338)
                             
Balance at June 30, 2020  -  $-   2,053,410,164  $2,053,410  $11,664,657  $(75,550,515) $(61,832,448)

  Years Ended 
  June 30,
2023
  June 30,
2022
 
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Income  974,979   90,030,933 
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities        
Depreciation & amortization expense  43,568   42,894 
Stock based compensation expense for services  22,372   960,700 
Conversion of stock options for services  32,875   - 
Net stock compensation expense for restricted stock awards  3,602,700   - 
Loss on redemption of marketable securities  -   76,792 
Loss on settlement of convertible note  42   1,835 
Loss on settlement of debt and derivative  664,627   1,109,761 
Net (Gain) Loss on change in derivative liability  (9,204,387)  (96,001,226)
Unrealized gain on change in fair value of investment, related party  (655,601)  - 
Amortization of debt discount recorded as interest expense  -   442,603 
Change in assets and liabilities :        
Prepaid expense  2,526   (2,526)
Other receivable  14,868   (14,868)
Accounts payable  175,504   (166,131)
Accrued expenses  (2,442)  (11,912)
Accrued interest on convertible notes  66,284   96,107 
NET CASH USED IN OPERATING ACTIVITIES  (4,262,085)  (3,435,038)
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Marketable securities purchased  (81,971,636)  (24,400,032)
Marketable securities redeemed  103,106,836   - 
Purchase of investment in affiliate  (7,000,000)  - 
Purchase of long term convertible note, affiliate  (3,000,000)  - 
Purchase of tangible assets  (33,814)  - 
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES:  11,101,386   (24,400,032)
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Net proceeds from purchase agreements  2,733,494   960,000 
Repayment of related party note payable  (68,291)  - 
Redemption of related parties stock options  -   (1,450,000)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES  2,665,203   (490,000)
         
NET INCREASE (DECREASE)  IN CASH  9,504,504   (28,325,070)
CASH, BEGINNING OF PERIOD  27,681,485   56,006,555 
CASH, END OF PERIOD  37,185,989   27,681,485 
         
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION        
Interest paid $6,033  $- 
Taxes paid     $- 
         
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS        
Fair value of common stock upon conversion of convertible notes , and accrued interest $260,489  $362,384 
Fair value of preferred stock in exchange for convertible note $17,475,309  $14,340,769 
Fair value of derivative liability removed $16,810,682  $13,231,008 
Reclassification of related party accrued salary to loan payable $211,750  $- 
Preferred stock issued upon exchange of convertible notes $-  $268,165 

The accompanying notes are an integral part of these audited financial statements


 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED JUNE 30, 2020 AND 2019

  Years Ended 
  June 30,
2020
  June 30,
2019
 
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Income (loss) $(57,529,338) $3,978,337 
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities        
Depreciation & amortization expense  8,419   6,988 
Stock based compensation expense  473,853   735,772 
Stock issued for services  357,134   249,435 
(Gain) Loss on change in derivative liability  54,910,562   (7,695,278)
Loss on conversion of debt  -   1,053,517 
Net loss on write-off of patent cost  5,426   - 
Amortization of debt discount recorded as interest expense  714,145   610,917 
Change in assets and liabilities :        
Prepaid expense  5,622   (11,058)
Other asset  -   900 
Accounts payable  76,257   13,996 
Accrued expenses  54,607   (23,247)
Accrued interest on convertible notes  227,529   226,028 
         
NET CASH USED IN OPERATING ACTIVITIES  (695,784)  (853,693)
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of tangible assets  (780)  (13,059)
         
NET CASH USED IN INVESTING ACTIVITIES:  (780)  (13,059)
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible notes payable  856,500   804,500 
         
NET CASH PROVIDED BY FINANCING ACTIVITIES  856,500   804,500 
         
NET INCREASE (DECREASE)  IN CASH  159,936   (62,252)
         
CASH, BEGINNING OF YEAR  35,074   97,326 
         
CASH, END OF YEAR $195,010  $35,074 
         
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION        
Interest paid $2,249  $940 
Taxes paid $-  $- 
         
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS        
Fair value of common stock upon conversion of convertible notes , accrued interest and other fees $1,377,186  $1,540,609 
Fair value of convertible notes at issuance $841,436  $743,301 

The accompanying notes are an integral part of these audited financial statements


SUNHYDROGEN, INC.
(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED–AUDITED

JUNE 30, 20202023 AND 20192022

 

1.1.ORGANIZATION AND LINE OF BUSINESS

 

Organization

SunHydrogen, Inc. (formerly HyperSolar, Inc.) (the “Company”) was incorporated in the state of Nevada on February 18, 2009. The Company, based in Santa Barbara, California,Coralville, IA began operations on February 19, 2009 to develop and market a solar concentrator technology.2009.

 

Line of Business

The company is currently developing a novel solar-powered nanoparticle system that mimics photosynthesis to separate hydrogen from water. We intend for technology of this system to be licensedused for the production of renewable hydrogen to produce renewable electricity and hydrogen for fuel cells.cells and other applications where hydrogen is used.

 

Going Concern

The accompanying audited financial statements have been prepared onSunHydrogen offers an efficient and cost-effective way to produce truly green hydrogen using sunlight and any source of water. Just like a going concern basissolar panel is comprised of accounting, which contemplates continuitymultiple cells that generate electricity, our hydrogen panel encases multiple hydrogen generators immersed in water. Each hydrogen generator contains billions of operations, realizationelectroplated nanoparticles, autonomously splitting water into hydrogen and oxygen. Our technology has the potential to be one of assets– if not the most – economical green hydrogen solutions: Unlike traditional water electrolysis for hydrogen, our process requires no external power other than sunlight and liabilitiesuses efficient and commitments in the normal course of business. The accompanying audited financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has historically obtained funds through private placement offerings of equity and debt. Management believes that it will be able to continue to raise funds by sale of its securities to its existing shareholders and prospective new investors to provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business. There is no assurance that the Company will be able to continue raising the required capital.low-cost materials.

 

2.2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of SunHydrogen, Inc (formerly HyperSolar, Inc.) is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Concentration risk

Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of the FDIC limits. As of June 30, 2023, the cash balance in excess of the FDIC limits was $30,044,164. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts.

Marketable Securities

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.

Corporate bonds and U.S. Treasuries are considered current, based on their liquidity. The investments are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.

Use of Estimates

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Cox Rubenstein binomialBinomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

 


2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Property and Equipment

Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.

Computers and peripheral equipment5 Years
Vehicle5 Years

The Company recognized depreciation expense of $36,535 and $35,861 for the years ended June 30, 2023 and 2022, respectively. 

Intangible Assets

The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Intangible Assets (Continued)

 Useful Lives 6/30/2020 6/30/2019  Useful Lives 6/30/2023  6/30/2022 
              
Domain-gross 15 years $5,315  $5,315  15 years $5,315  $5,315 
Less accumulated amortization  (4,223)  (3,868)    (5,286)  (4,931)
Domain-net $1,092  $1,447    $29  $384 
                  
Trademark-gross 10 years $1,143  $1,143  10 years $1,143  $1,143 
Less accumulated amortization  (371)  (257)    (714)  (601)
Domain-net $772  $886    $429  $542 
                  
Patents-gross 15 years $107,491  $107,491  15 years $101,143  $101,143 
Write-off of patent cost  (6,349)  - 
Less accumulated amortization  (16,650)  (10,391)    (36,344)  (29,779)
Patents-net $84,492  $97,100    $64,799  $71,364 

 

The Company recognized amortization expense of $7,651$7,033 and $6,360$7,033 for the years ended June 30, 20202023 and 2019,2022, respectively.

 

Property and Equipment

Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives:

Computers and peripheral equipment5 Years

Depreciation expense for the years ended June 30, 2020 and 2019 was $768 and $628, respectively.

Net Earnings (Loss) per Share Calculations

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). 

 

For the year endedYear Ended June 30, 2020, the2023

The Company calculated the dilutive impact of the218,394,499 outstanding stock options, 86,495,239 common stock purchase warrant, and 10,951 shares of 186,000,000,Series C Preferred shares, which are convertible into shares of common stock. The 86,495,239 warrants and 208,394,499 stock options, and 10,951 preferred shares, were included because their impact is dilutive, and 10,000,000 stock options were not included, because their impact on income per share is antidilutive.

Year Ended June 30, 2022

The Company calculated the dilutive impact of 157,965,711 outstanding stock options, 94,895,239 common stock purchase warrants, and the convertible debt and accrued interest of $2,030,000,$1,003,108, which is convertible into shares of common stock. The common stock options and convertible debtpurchase warrants were not included in the calculation of net earnings per share, because their impact was antidilutive.on income per share is dilutive.

  Years Ended 
  June 30, 
  2023  2022 
       
Income (Loss) to common shareholders (Numerator) $979,479  $90,030,933 
         
Basic weighted average number of common shares outstanding (Denominator)  4,492,448,483   4,103,301,026 
         
Diluted weighted average number of common shares outstanding (Denominator)  4,787,349,172   5,217,576,101 


2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Equity Incentive Plan and Stock Options

 

ForOn January 27, 2022, the Company adopted the 2022 Equity Incentive Plan, to enable the Company to attract and retain the types of employees, consultants, and directors who will contribute to the Company’s long-range success. The maximum number of shares of common stock that may be issued under the 2022 Plan is initially 400,000,000. The number of shares will automatically be increased on the first day of the Company’s fiscal year beginning in 2023 so that the total number of shares issuable will at all times equal fifteen percent (15%) of the Company’s fully diluted capitalization on the first day of the Company’s fiscal year, unless the Board adopts a resolution providing that the number of shares issuable under the 2022 Plan shall not be so increased. During the year ended June 30, 2019,2023, the Company calculatedgranted restricted stock in the dilutive impactamount of its outstanding stock options of 186,250,000, and convertible debt of $2,320,486, which is convertible into120,600,000 shares of common stock. The stock options and convertible debt were not includedwhich 110,600,000 vested in the calculationperiod. Ten Million shares will vest on January 1, 2024. As of net earnings per share, because their impact was antidilutive.June 30, 2023 there were 279,400,00 in the reserve. As of July 1, 2023, the plan increased to 723,194,742 shares.

 

  For the Years Ended 
  June 30, 
  2020  2019 
       
Income (Loss) to common shareholders (Numerator) $(57,529,338) $3,978,337 
         
Basic weighted average number of common shares outstanding (Denominator)  1,551,749,054   924,582,860 
         
Diluted weighted average number of common shares outstanding (Denominator)  1,551,749,054   924,582,860 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Equity Incentive Plan and Stock Options

 

Equity Incentive Plan

On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares of common stock set aside and reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Company and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. TheAs of September 2020, the Company issued 124,304,650 shares are convertible intoof common stock upon exercise.for consulting services. The Company granted options to purchase 170,000,000 shares of common stock options on January 23, 2019. On July 29, 2022, the Company granted restricted stock awards of 21,500,000 shares to an employee for services, which vested on March 30, 2023. On June 1, 2023, the Company granted 9,000,000 non-statutory stock options to employees for services, which one-third (1/3) vested immediately, and the remainder shall vest one-twenty fourth (1/24) per month from months thirteen (13) through thirty-six (36) after the date of this option. As of June 30, 2020,2023, the Company had redemptions of 38,034,089 shares of stock, which were added back to the total reserve.

As of June 30, 2023, under the 2019 Equity Incentive Plan, there were 186,000,000 stock options issued, and 114,000,000 additional shares reserved under the Plan.

Stock based Compensation

The Company periodically issues286,770,561 stock options and warrants to employeesshares issued, and non-employees in non-capital raising transactions for services and for financing costs. a reserve of 13,229,439.

Stock Based Compensation

The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, the option grants are immediately vest,vested, and the total stock-based compensation charge is recorded in the period of the measurement date. As of June 30, 2020, 10,000,000 of such options were outstanding.


2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Warrant Accounting

 

The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.

Fair Value of Financial Instruments

 

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized inon the balance sheet, where it is practicable to estimate that value. As of June 30, 2020,2023, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

  

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;markets.

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; andactive.

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2020 and 2019 (See Note 6):

 

  Total  (Level 1)  (Level 2)  (Level 3) 
             
Liabilities            
                 
Derivative liability measured at fair value at 6/30/20 $59,657,719  $       -  $          -  $59,657,719 
                 
Derivative liability measured at fair value at 6/30/19 $3,905,721  $-  $-  $3,905,721 
  Total  (Level 1)  (Level 2)  (Level 3) 
Assets:            
Cash and cash equivalents at June 30, 2023 $37,185,989  $37,185,989  $-  $- 
Marketable securities measured at fair value June 30, 2023 $10,843,641  $-  $10,843,641  $- 
  $48,029,630  $23,257,437  $10,843,641  $- 
                 
Cash and cash equivalents at June 30, 2022 $27,681,485  $27,681,485  $-  $- 
Marketable securities measured at fair value June 30, 2022 $24,323,240  $-  $24,323,240  $- 
  $52,004,725  $27,681,485  $24,323,240  $- 
                 
Liabilities:                
Derivative liabilities measured at fair value June 30, 2023 $-  $-  $-  $- 
Derivative liabilities measured at fair value June 30, 2022 $26,015,069  $-  $-  $26,015,069 

 

Fair Value of Financial Instruments (Continued)

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

 

Balance as of June 30, 2018 $10,857,698 
Fair value of derivative liabilities at issuance  743,301 
Gain on change in derivative liability  (7,695,278)
Balance as of June 30, 2019  3,905,721 
Fair value of derivative liabilities issued  841,436 
Loss on change in derivative liability  54,910,562 
Balance as of June 30, 2020 $59,657,719 
Balance as of June 30, 2022 $26,015,069 
Fair value of derivative liability removed  (16,810,682)
Gain on change in derivative liability  (9,204,387)
Balance as of June 30, 2023 $- 

 

As of June 30, 2023, the derivative liability balance was $0.


2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Research and Development

Research and development costs are expensed as incurred.  Total research and development costs were $615,721$3,440,106 and $528,901$1,792,457 for the years ended June 30, 20202023 and 2019,2022, respectively.

 

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Income TaxesReclassification of Expenses

Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported

Certain amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all2022 financial statements have been reclassified to conform to the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained.  The benefit of a tax position is recognizedpresentation used in the 2023 financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.  Tax positions taken are not offset or aggregated with other positions.  Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than (50%) fifty percent likely of being realized upon settlement with the applicable taxing authority.  The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Recently Issued Accounting Pronouncements

In August 2017, FASB issued accounting standards update ASU-2017-12, (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earningsstatements. There was no material effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company does not believe the adoption of ASU-2017 would have a material impact on the Company’s previously issued financial statements.

 

In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company’s financial statements.

In August 2018, the FASB issued to accounting standards update ASU 2018-13, (Topic 820) - “Fair Value Measurement”, which changes the unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance. The Company is currently evaluation the impact of the adoption of ASU 2018-13, on the Company’s financial statements.

In December 2019, the FASB issued to accounting standards amendment updates to ASU 2019-12, (Topic 740) – “Income Taxes”, which simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The amendments in this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods with fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company does not believe the adoption of ASU-2019-12, would have a material impact on the Company’s financial statements.Recently Issued Accounting Pronouncements

 

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensedunaudited financial statements.statements as of June 30, 2023.

 

3.3.CAPITAL STOCKSSTOCK

 

Year endedSeries C Preferred Stock

On December 15, 2021, the Company filed a certificate of designation of Series C Preferred Stock with the Secretary of State of Nevada, designating 17,000 shares of preferred stock as Series C Preferred Stock. Each share of Series C Preferred Stock has a stated value of $100 and is convertible into shares of common stock of the Company at a conversion price equal to $0.00095. The Series C Preferred Stockholders are entitled to receive out of any funds and assets of the Company legally available prior and in preference to any declaration or payment of any dividend on the common stock of the Company, cumulative dividends, at an annual rate of 10% of the stated value, payable in cash or shares of common stock. In the event the Company declares or pays a dividend on its shares of common stock (other than dividend payable in shares of common stock), the holders of Series C Preferred Stock will also be entitled to receive payment of such dividend on an as-if-converted basis. The Series C Preferred Stock confers no voting rights on holders, except with respect to matters that materially and adversely affect the voting powers, rights or preferences of the Series C Preferred Stock or as otherwise required by applicable law.

On December 15, 2021, the Company entered into a securities purchase agreement with an accredited investor for an exchange of convertible debt to equity. Under the purchase agreement, the Company and investor acknowledged there was $187,800 of principal remaining under the note issued to the investor by the Company on February 3, 2017, plus $80,365 of accrued interest, representing a total aggregate note balance of $268,165. Pursuant to the purchase agreement, the Company sold to the investor 2,700 shares of the Company’s newly designated Series C Preferred Stock for a total purchase price of $268,165, and a loss on settlement of debt of $1,835. On April 15, 2023, the Company entered into another securities purchase agreement with the investor to exchange the remaining notes with principal $550,000, plus accrued interest of $126,455, representing a total aggregate note balance of $676,455, and a loss on settlement of debt of $45. Pursuant to the purchase agreement, the Company sold 6,765 shares of the Company’s designated Series C Preferred Stock to the investor, for a total purchase price of $676,455. The investor tendered the Note to the Company for cancellation and agreed to forgo all future accrued interest under the Note, as the total purchase price for the shares. As of June 30, 20202023, the Company had a total of 9,465 shares of Series C Preferred Stock outstanding with a fair value of $946,500, and a stated face value of one hundred dollars ($100) (“share value’) per share, convertible into shares of common stock of the Company. The stock was presented as mezzanine equity because it is redeemable at a fixed or determinable amount upon an event that is outside of the issuer’s control. Upon liquidation, dissolution and winding up of the Company, the holder of each outstanding share of Series C Preferred Stock shall be entitled to receive, out of the assets of the Company available for distribution to its shareholders upon such liquidation, before any payments shall be made or any assets distributed to the holders of the common stock, the stated value of the Series C Preferred Shares plus any declared but unpaid dividends. No other current or future equity holders of the Company shall have higher priority of liquidation preference than holders of Series C Preferred Stock. The holder has the right, at any time, at its election, to convert shares of Series C Preferred Stock into common stock at a conversion price of $0.00095 per share.


3.CAPITAL STOCK (Continued)

On June 19, 2023, the Company entered into a securities purchase agreement with an accredited investor for an exchange of convertible debt to equity. Under the purchase agreement, the Company and investor acknowledged there was an aggregate of $100,000 of principal outstanding under the Note issued to the investor by the Company on August 10, 2018, plus $48,603 of accrued interest, representing a total aggregate note balance of $148,603. Pursuant to the Purchase Agreement, the Company issued and sold to the investor 1,486 shares of the Company’s Series C Preferred Stock for a total purchase price of $148,603, and a gain on settlement of debt of $3. The investor tendered the Note to the Company for cancellation and agreed to forego all future accrued interest under the Note, as the total purchase price for the shares.

As of June 30, 2023, the Company had a total of 10,951 shares of Series C Preferred Stock outstanding with a fair value of $1,095,100, and a stated face value of one hundred dollars ($100) (“share value’) per share, convertible into shares of common stock of the Company. Upon liquidation, dissolution and winding up of the Company, the holder of each outstanding share of Series C Preferred Stock shall be entitled to receive, out of the assets of the Company available for distribution to its shareholders upon such liquidation, before any payments shall be made or any assets distributed to the holders of the common stock, the stated value of the Series C Preferred Shares plus any declared but unpaid dividends. No other current or future equity holders of the Company shall have higher priority of liquidation preference than holders of Series C Preferred Stock. The holder has the right, at any time, at its election, to convert shares of Series C Preferred Stock into common stock at a conversion price of $0.00095 per share.

During the year ended June 30, 2020,2023, the Company entered into a purchase agreement with investors for an exchange of convertible debt into equity. The investors exchanged convertible notes in the amount of $837,800, plus interest in the amount of $255,423, and an aggregate loss of $1,877 for an aggregate total of $1,095,100 in exchange for 10,951 shares of the Company’s Series C Preferred Stock. The extinguishment of the convertible debt and derivative was recognized in the Company’s financial statement as a loss on settlement of convertible notes and derivative liability in the amount of $664,627. A valuation was prepared based on a stock price of $0.020 as of April 15, 2023 and $0.0185 as of June 19, 2023, with a volatility of 96.6%, as of April 15, 2023 and 82.9% as of June 19, 2023 based on an estimated term of 5 years.

The stock was presented as mezzanine equity because it is redeemable at a fixed or determinable amount upon an event that is outside of the issuer’s control.

Exchange of convertible notes to Series C Preferred Shares   
Preferred shares issued  10,951 
Stated value of debt and interest $1,095,100 
Calculated fair value of preferred shares $17,475,309 
Fair value of derivative liability removed $(16,810,682)
Loss on settlement of debt and derivatives $(664,627)

The Company recognized a loss on settlement of $664,627 for the extinguishment of convertible debt, plus derivative liability for the year ended June 30, 2023.

Common Stock

On January 27, 2022, the holder of the majority of the voting power of the shareholders of the Company, and the Company’s chief executive officer, approved by written consent (i) an amendment to the Company’s articles of incorporation to increase the Company’s authorized shares of common stock from 5,000,000,000 to 10,000,000,000, (ii) an amendment to the Company’s articles of incorporation to effect a reverse stock split of the Company’s common stock by a ratio of not less than 1-for-100 and not more than 1-for-500 at any time prior to the one year anniversary of filing the definitive information statement with respect to the reverse split, with the board of directors having the discretion as to whether or not the reverse split is to be effected, and with the exact ratio of any reverse split to be set at a whole number within the above range as determined by the board in its discretion, and (iii) the adoption of the Company’s 2022 Equity Incentive Plan. Shareholder approval for such actions became effective 20 days after the definitive information statement relating to such actions was mailed to shareholders.

Year ended June 30, 2023

During the year ended June 30, 2023, the Company issued 884,989,722274,198,530 shares of common stock upon conversion of convertible notes in the amount of $1,166,986 in$177,500 of principal, plus accrued interest of $198,200 and other fees of $12,000$82,989 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.


3.CAPITAL STOCK (Continued)

On November 11, 2022, the Company entered into a Purchase Agreement with an investor for a total of $45,000,000 to purchase shares of common stock. During the year ended June 30, 2023, the Company issued 141,316,753 shares of common stock for $2,733,494 under a purchase agreement at prices rangingof $0.01264 - $0.02608, pursuant to the purchase notices received from $0.00095 - $0.0041.the investor. The finance cost of $52,970 was deducted from the gross proceeds converted.

 

During the year ended June 30, 2020,2023, a consultant exercised 3,071,412 nonqualified stock options with an exercise price of $0.01 and a market price of $0.027 per share. Upon exercise of the stock options, the Company issued 91,101,1031,933,852 shares of common stock for services renderedthrough a cashless exercise at fair value pricesthe price of $0.002 - $0.0072$0.017 per share in the amountfor compensation expense of $357,134.$32,875.

 

Year ended June 30, 2019

During the year ended June 30, 2019,2023, two employees were granted 150,000,000 restricted stock awards for services, which vested immediately. The Company withheld 62,400,000 shares at a price of $0.027 to pay for the taxes owed by the employees in the amount of $1,684,800, and the remaining 87,600,000 shares priced at $0.027 per share in the amount of $2,365,200 in stock compensation was reported in the financial statements.

Year ended June 30, 2022

During the year ended June 30, 2022, the Company issued 195,464,064381,457,044 shares of common stock upon conversion of convertible notes in the amount of $411,814 in$255,900 of principal, plus accrued interest of $75,278 with an aggregate fair value$106,484 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of their respective agreements and therefore no gain or loss on settlement of $1,053,517 based uponthe conversion prices ranging from $0.0055 to $0.0099was recorded.

 

During the year ended June 30, 2018,2022, the Company issued 29,397,25740,983,607 shares of common stock pursuant to a purchase agreement for services renderedcash at a fair value pricesprice of $0.0063 - $0.0105$0.02745 per share in the amountfor aggregate net proceeds of $249,435.$960,000.

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

4.4.OPTIONS AND WARRANTS

 

Stock OptionRESTRICED STOCK AWARDS

On July 29, 2022, the Board of Directors determined that in the best interest of the Company and the Shareholders to grant an employee a restricted stock award in consideration of services to be rendered to the Company. The Board granted 21,500,000 shares of restricted stock awards, which vested on March 30, 2023. Under the 2019 Equity Incentive Plan,

The non-qualified an employee was granted 21,500,000 restricted stock awards at a price of $0.025 per share for services, which vested on March 30, 2023. During the year ended June 30, 2023, the Company issued 21,500,000 shares of common stock and recorded stock compensation expense of $537,500, which was reported in the financial statements.

On November 8, 2022 and December 20, 2022, the Board of Directors determined that in the best interest of the Company and the Shareholders, to grant certain employees, a director and a consultant restricted stock awards in consideration of services to be rendered to the Company. The Board granted 33,000,000 shares of restricted stock awards, whereby, 23,000,000 shares vested on January 1, 2023 and 10,000,000 shares will vest on January 1, 2024. Under the 2022 Equity Incentive Plan, an employee, a director and consultant were granted 33,000,000 restricted stock awards at a price of $0.025 per share for services, whereby 23,000,000 shares vested on January 1, 2023 and 10,000,000 will vest on January 1, 2024. During the year ended June 30, 2023, the Company issued 23,000,000 shares of common stock, and recorded stock compensation expense of $700,000, which was reported in the financial statements.

OPTIONS

On October 2, 2017, the Company granted non-qualified options expireto purchase 10,000,000 shares of common stock. Each option expires on the date specified in the option agreement, which date is not later than the fifth (5th) anniversary from the grant date of the options. As of June 30, 2020, 250,000 options were fully vested with a maturity date of March 31, 2020, which expired and were forfeited as of June 30, 2020; on October 2, 2017,Of the Company issued 10,000,000 non-qualified common stock options, whichone-third vest one-third immediately, and one-third vest the second and third year, whereby,such that the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share. As of June 30, 2022, the consultant had redeemed 6,928,788 options, leaving a balance of 3,071,412 options. The remaining options of 3,071,412 were fully exercised during the year ended June 30, 2023.

 


4.OPTIONS AND WARRANTS (Continued)

On January 23, 2019, the Company issued 170,000,000 stock options. One-third of the options of which one-third (1/3) vestvested immediately, and the remaining shallremainder vest one-twenty fourth (1/24)1/24 per month afterover the date of thesefirst twenty-four months following the option grant. The options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years.expire 10 years from the initial grant date. The options fully vestvested by January 23, 2021.2022.

 

On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vestvested immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of thesethe option grant. The options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years.expire 10 years from the initial grant date. The options fully vested on January 31, 2020.

 

On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vestvested immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of thesethe option grant. The options (remaining block). The first block shall become exercisable immediately and is exercisable for a period of seven (7) years.expire 10 years from the initial grant date. The options fully vest byvested on July 22, 2021.2020.

 

A summary of the Company’s stock option activity and related information follows:

 

 6/30/2020 6/30/2019  6/30/2023 6/30/2022 
   Weighted   Weighted     Weighted     Weighted 
 Number average Number average  Number average Number average 
 of exercise of exercise  Of exercise Of exercise 
 Options price Options price  Options price Options price 
Outstanding, beginning of period  186,250,000  $0.01   10,250,000  $0.01   157,965,711  $0.0089   157,965,711  $0.0089 
Granted  10,000,000  $0.01   176,000,000  $0.01   9,000,000  $0.0160   -   - 
Exercised  -   -   -   -   -  $0.01   -   - 
Forfeited/Expired  (250,000)  -   -   - 
Redemption of options  (3,071,212)  -   -   - 
Outstanding, end of period  196,000,000  $0.01   186,250,000  $0.01   163,894,499  $0.098   157,965,711  $0.0089 
Exercisable at the end of period  160,493,150  $0.01   85,583,333  $0.01   157,894,499  $0.094   157,965,711  $0.0089 

Year ended June 30, 2023

During the year ended June 30, 2023, a consultant redeemed 3,071,212 nonqualified stock options through a cashless exercise for 1,933,852 options, and used the remaining 1,137,360 options for the cost of the cashless exercise. The options were fully vested and previously expensed accordingly.

Under the 2019 Equity Incentive Plan, employees were granted 9,000,000 shares of options at a price per share of $0.016, which vest on June 1, 2026. The Company recorded stock compensation expense of $22,372, which was reported in the financial statements.

Year ended June 30, 2022

During the year ended June 30, 2022, the Company redeemed a total of 24,887,463 shares of the Company’s stock options from related parties for a total of $1,450,000, leaving a balance of $157,965,711 stock options outstanding.

 

The weighted average remaining contractual life of options outstanding as of June 30, 20202023 and 20192022 was as follows:

 

6/30/2020  6/30/2019 
Exercisable
Price
  Stock Options Outstanding  Stock Options Exercisable  Weighted Average Remaining Contractual Life (years)  Exercisable Price  Stock Options Outstanding  Stock Options Exercisable  Weighted Average Remaining Contractual Life (years) 
$-   -   -   -  $0.02   250,000   250,000   0.75 
$0.01   10,000,000   10,000,000   1.26  $0.01   10,000,000   5,250,000   3.26 
$0.0097-0.0099   176,000,000   144,018,263   5.57 – 5.59  $0.0097-0.0099   176,000,000   60,666,667   6.57 - 6.84 
$0.0060   10,000,000   6,474,887   6.06  $-   -   -   - 
     196,000,000   160,493,150           186,250,000   85,583,333     

6/30/206/30/19
Risk free interest rate1.47% - 2.58%1.94%
Stock volatility factor54.99% - 189.01%146%
Weighted average expected option life6 years7 years
Expected dividend yield NoneNone
6/30/2023  6/30/2022 
Exercise
Price
  Stock
Options
Outstanding
  Stock
Options
Exercisable
  Weighted
Average
Remaining
Contractual
Life (years)
  Exercise
Price
  Stock
Options
Outstanding
  Stock
Options
Exercisable
  Weighted
Average
Remaining
Contractual
Life (years)
 
$-   -   -   -  $0.0100   3,071,212   3,071,212   0.76 
$0.016   9,000,000   3,000,000   2.92  $-   -   -   - 
$0.0097   6,000,000   6,000,000   2.59  $0.0097   6,000,000   6,000,000   3.59 
$0.0099   138,894,499   138,894,499   2.57  $0.0099   138,894,499   138,894,499   3.57 
$0.0060   10,000,000   10,000,000   3.06  $0.0060   10,000,000   10,000,000   4.06 
     163,894,499   157,894,499           157,765,711   157,965,711     

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

4.OPTIONS AND WARRANTS (Continued)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019WARRANTS

 

4.OPTIONS (Continued)

Stock Option Plan (Continued)

As of June 30, 2023, the Company had an aggregate of 86,495,239 common stock purchase warrants outstanding, with exercise prices ranging from $0.0938 - $0.13125 per share. The stock-based compensation expense recognized inwarrants were estimated at fair value on the statementdate of operations duringissuance as calculated using the yearsBlack-Scholes valuation model. The derivative liability calculated on all warrants outstanding as of the year ended June 30, 20202023, was removed with the exchange of the convertible notes and 2019, relatedaccrued interest for preferred shares. (See Note 6). The warrants can be exercised over periods of three (3) to the granting of these options was $473,853 and $735,772, respectively.five (5) years.

 

A summary of the Company’s warrant activity and related information follows for the year ended June 30, 2023

  6/30/2023 
     Weighted 
  Number  average 
  of  exercise 
  Warrants  price 
Outstanding, beginning of period  94,895,239  $0.11 
Granted  -   - 
Exercised  -   - 
Forfeited/Expired  (8,400,000) $.0938 
Outstanding, end of period  86,495,239  $0.12 
Exercisable at the end of period  86,495,239  $0.12 

6/30/23  Weighted Average 
Exercise
Price
  Warrants
Outstanding
  Warrants
Exercisable
  Remaining Contractual
Life (years)
 
$0.0938   8,400,000   8,400,000   0.50 
$0.13125   6,666,667   6,666,667   2.66 
$0.12   71,428,572   71,428,572   2.67 
     86,495,239   86,495,239     

At June 30, 2023, the aggregate intrinsic value of the warrants outstanding was $0.

5.5.CONVERTIBLE PROMISSORY NOTES

 

As of June 30, 2020, the2023, there were no outstanding convertible promissory notes. All convertible notes net of debt discount of $409,074 are summarized as follows:

Convertible Promissory Notes, net of debt discount $1,620,926 
Less current portion  160,926 
Total long-term liabilities $1,460,000 

Maturities of long-term debt principalwere exchanged for the next four years are as follows:

Period Ended   
June 30, Amount 
2021  570,000 
2022  575,000 
2023  745,000 
2024  140,000 
  $2,030,000 

At June 30, 2020, the $2,030,000 in convertible promissory notes had a remaining debt discount of $409,074, leaving a net balance of $1,620,926.

The Company issued a 10% convertible promissory note on April 9, 2015 (the “April 2015 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $50,000. The Company received additional tranches in the amount of $450,000 for an aggregate sum of $500,000. The April 2015 Note matured nine (9) months from the effective dates of each respective tranche. A second extension was granted to October 9, 2016. On January 19, 2017, the investor extended the April 2015 Note for an additional (60) months from the effective date of each tranche, which had a maturity date of April 9, 2020.The April 2015 Note was convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. In no event could the lender convert any portion of the April 2015 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. During the year ended June 30, 2020, the Company issued 212,079,164 shares of common stock, upon conversion of $192,600, plus accrued interest of $74,285. The balance of the April 2015 Note as of June 30, 2020 was $0.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

5.CONVERTIBLE PROMISSORY NOTES (Continued)

The Company issued a 10% convertible promissory note on January 28, 2016 (the “Jan 2016 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $10,000. The Company received additional tranches in the amount of $490,000 for an aggregate sum of $500,000. The Jan 2016 Note matures twelve (12) months from the effective dates of each respective tranche. On January 19, 2017, the investor extended the Jan 2016 Note for an additional sixty (60) months from the effective date of each tranche, which matures on January 27, 2022. The Jan 2016 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jan 2016 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the year ended June 30, 2020, the Company issued 280,606,492 common shares upon conversion of principal in the amount of $190,000, plus interest of $76,576. The balance of the Jan 2016 Note as of June 30, 2020 was $310,000.

The Company issued a 10% convertible promissory note on February 3, 2017 (the “Feb 2017 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $60,000. The Company received additional tranches in the amount of $440,000 for an aggregate sum of $500,000. The Feb 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Feb 2017 Note had a maturity date of February 3, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche. The Feb 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranche or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Feb 2017 Note as of June 30, 2020 was $500,000.Series C Preferred Shares.

 

The Company issued a 10% convertible promissory note on November 9, 2017 (the “Nov 2017 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, the Company received a tranche of $45,000. The Company received additional tranches in the amount of $455,000 for an aggregate sumprincipal total of $500,000. The Nov 2017 Note matures twelve (12) months from the effective dates of each respective tranche. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of each tranche.the note. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranchethe note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note to the extent such thatconversion would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balanceDuring the year ended June 30, 2023, the Company issued 274,198,530 shares of common stock upon the Nov 2017 Note asconversion of principal in the amount of $177,500, plus accrued interest of $82,989. As of June 30, 20202023, the balance remaining was $500,000.$0.

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

 

5.5.CONVERTIBLE PROMISSORY NOTES (Continued)

 

The Company issued a 10% convertible promissory note on June 27, 2018 (the “Jun 2018 Note”) in the aggregate principal amount of up to $500,000. Upon execution of the convertible promissory note, theThe Company received a tranchetranches for an aggregate principal total of $50,000. On October 9, 2018, the Company received another tranche of $40,000, for a total aggregate of $90,000 as of December 31, 2019. The Jun 2018 Note matures twelve (12) months from the effective dates of each respective tranche.$500,000. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of each tranche.the note. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective tranchethe note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note to the extent such thatconversion would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $2,823 during the year ended June 30, 2020. The balance of the Jun 2018 Note as of $500,000, plus interest was exchanged for Series C Preferred Shares, leaving a remaining balance at June 30, 2020 was $90,000.2023 of $0.

 

The Company issued a 10% convertible promissory note on August 10, 2018 (the “Aug 2018 Note”) in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $11,233 during the year ended June 30, 2020. The balance of the Aug 2018 Note as of $100,000, plus interest was exchanged for Series C Preferred Shares, leaving a remaining balance at June 30, 2020 was $100,000.

The Company issued 10% convertible promissory notes on February 14, 2019 thru August 12, 2019, (the “Feb-Aug Notes”) in the aggregate principal amount2023 of up to $252,000. The Feb-Aug Notes had maturity dates of February 14, 2020 thru August 12, 2020. The Feb-Aug Notes were convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb-Aug Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the year ended June 30, 2020, the Company issued 116,025,867 shares of common stock upon conversion of principal in the amount of $252,000, plus accrued interest of $12,600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $176,288 during the year ended June 30, 2020.  The balance of the Feb-Aug Notes as of June 30, 2020 was $0.

On December 14, 2018, January 18, 2019, and July 3, 2019, the Company issued convertible promissory notes (the “Dec-Jul Notes”) to an investor, (the “Dec-Jul Notes”) in the total aggregate principal amount of $140,000. The Dec-Jul Notes had maturity dates of December 14, 2019 and January 18, 2020. The Dec-Jul Notes were convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Dec-Jul Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended June 30, 2020, the Company issued 103,302,185 shares of common stock upon conversion of $132,386 in principal, plus accrued interest of $14,000, and legal fees of $9,000. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $91,714 during the year ended June 30, 2020. The balance of the Dec-Jul Notes as of June 30, 2020 was $0.

On January 31, 2019 and March 6, 2019, the Company issued convertible promissory notes (the “Jan-Mar Note”) to an investor (the “Jan-Mar Note”) in the total aggregate principal amount of $160,000. The Jan-Mar Notes had maturity dates of January 31, 2020 and March 6, 2020. The Jan-Mar Notes were convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jan-Mar Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Mar Notes. The Company issued 76,591,844 shares of common stock upon the conversion of principal in the amount of $160,000, plus accrued interest of $8,399, and legal fees of $1,500. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $101,698 during the year ended June 30, 2020. The balance of the Jan-Mar Notes as of June 30, 2020 was $0.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

5.CONVERTIBLE PROMISSORY NOTES (Continued)

On August 28, 2019, the Company issued a convertible promissory note (the “Aug Note”) to an investor, in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Aug Note had a maturity date of August 28, 2020. The Aug Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Aug Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug Note. During the year ended June 30, 2020, the Company issued 30,227,789 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,219, and legal fees of $600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $58,835 during the year ended June 30, 2020. The balance of the Aug Note as of June 30, 2020 was $0.

On October 2, 2019, the Company issued a convertible promissory note (the “Oct Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Oct Note matures on October 2, 2020. The Oct Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Oct Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Oct Note. During the year ended June 30, 2020, the Company issued 39,676,622 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,110, and legal fees of $600. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $80,000, during the year ended June 30, 2020. The balance of the Oct Note as of June 30, 2020 was $0.

On November 27, 2019, the Company issued a convertible promissory note (the “Nov Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Nov Note had a maturity date of November 27, 2020. The Nov Note was convertible into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average of the two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Nov Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Nov Note. During the year ended June 30, 2020, the Company issued 26,579,747 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $4,011, and legal fees of $300. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $80,000 during the year ended June 30, 2020. The balance of the Nov Note as of June 30, 2020 was $0.

On January 10, 2020, the Company issued a convertible promissory note (the “Jan 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Jan 2020 Note matures on January 10, 2021. The Jan 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the thirty (30) trading day prior to the conversion date. The conversion feature of the Jan 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $37,596 during the year ended June 30, 2020. The balance of the Jan 2020 Note as of June 30, 2020 was $80,000.

On February 11, 2020, the Company issued a convertible promissory note (the “Feb 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The Feb 2020 Note matures on February 11, 2021. The Feb 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $30,601 during the year ended June 30, 2020. The balance of the Feb 2020 Note as of June 30, 2020 was $80,000.


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

5.CONVERTIBLE PROMISSORY NOTES (Continued)

On March 5, 2020, the Company issued a convertible promissory note (the “Mar 2020 Note”) to an investor in the principal amount of $40,000. The Company received funds of $38,000, less other fees of $2,000. The Mar 2020 Note matures on March 9, 2021. The Mar 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Mar 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Mar 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $11,528 during the year ended June 30, 2020. The balance of the Mar 2020 Note as of June 30, 2020 was $40,000.

On April 14, 2020, the Company issued a convertible promissory note (the “April 2020 Note”) to an investor in the principal amount of $80,000. The Company received funds of $78,000, less other fees of $2,000. The April 2020 Note matures on April 14, 2021. The April 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the April 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $16,658 during the year ended June 30, 2020. The balance of the April 2020 Note as of June 30, 2020 was $80,000.

 

On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000, of which the$50,000. The Company received $10,000 astranches for an aggregate principal total of June 30, 2020.$50,000. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of the common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note to the extent such thatconversion would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $706 during the year ended June 30, 2020. The balance of the Apr 2020 Note of $50,000, plus interest was exchanged for Series C Preferred Shares, leaving a remaining balance as of June 30, 2020 was $10,000.

On May 19, 2020, the Company issued a convertible promissory note (the “May 2020 Note”) to an investor in the principal amount2023 of $80,000. The Company received funds of $78,000, less other fees of $2,000. The May 2020 Note matures on May 19, 2021. The May 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the May 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the May 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $9,205 during the year ended June 30, 2020. The balance of the May 2020 Note as of June 30, 2020 was $80,000.$0.

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

6.5.CONVERTIBLE PROMISSORY NOTES (Continued)

DERIVATIVE LIABILITIES

 

On June 18, 2020, the Company issued a convertible promissory note (the “June 2020 Note”) to an investor in the principal amount of $160,000. The Company received funds of $156,000, less other fees of $4,000. The Jun 2020 Note matures on June 19, 2021. The Jun 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the average of the lowest two (2) trading prices per common stock during the fifteen (15) trading day prior to the conversion date. The conversion feature of the Jun 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jun 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $5,260 during the year ended June 30, 2020. The balance of the Jun 2020 Note as of June 30, 2020 was $160,000.

All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

6.DERIVATIVE LIABILITIES

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.

 

The


6.

DERIVATIVE LIABILITIES (Continued)

In accordance with ASC No. 820, “Fair Value Measurements and Disclosures”, the Company measures its liability related to convertible notes (the “Notes”) issued do not have fixed settlement provisionsand warrants at fair value using Black Scholes. They are valued using alternative pricing sources and models utilizing market observable inputs. The liability related to the convertible notes and warrants is classified within Level 3 value hierarchy because their conversion pricesthe liability is based on present value calculations and external valuation models whose inputs include market interest rates, estimated operational capitalization rates, volatilities and illiquidity. Unobservable inputs used in these models are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.significant.

 

During the year ended June 30, 2020, as2023, the Company recorded a resultnet gain change in derivative of $9,204,387 in the statement of operations, due to the removal of the Notes issued that were accountedderivatives for as derivative liabilities, we determined thatthe warrants and the convertible notes, for the exchange of the convertible notes and accrued interest for Series C Preferred Shares.

For the years ended June 30, 2023 and 2022, the fair value of the conversion featurederivative liabilities are as follows;

  6/30/2023  6/30/2022 
       
Derivative liability, convertible notes and accrued interest $         -  $24,528,774 
Derivative liability, warrants  -   1,486,295 
Total $-  $26,015,069 

7.CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, AND EQUITY INVESTMENT, RELATED PARTY

As of June 30, 2023, the Company invested in corporate bonds and government bonds, which have been recognized in the financial statements at cost.

The Company considers corporate bonds and government bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the convertible notes at issuance was $841,436, based uponcorporation’s debt structure, as well as the Cox Rubenstein binomial model. We recordedoverall health of the fulleconomy. The bonds fall into the category as investments if they have a rating between AA and BBB.

As of June 30, 2023, the components of the Company’s cash, cash equivalents, short -term investments are summarized as follows:

  Adjusted
Cost
  Unrealized
Gains
  Unrealized
Losses
  Fair Value  Cash and
Cash
Equivalents
  Short-Term
Marketable
Securities
 
Cash $13,928,552  $-  $-  $-  $13,928,552  $- 
                         
Subtotal  13,928,552   -   -   -   13,928,552   - 
                         
Level 1                        
U.S. Treasury bills and Obligations  23,257,437   -   -   -   23,257,437   - 
Subtotal  23,257,437   -   -   -   23,257,437   - 
                         
Level 2                        
Corporate securities  3,188,040   -   (193,006)  2,995,034   -   3,188,040 
Investment, related party  7,000,000   655,601   -   7,655,601   -   7,000,000 
                         
Subtotal  10,188,040   655,600   (193,006)  10,650,635   -   10,188,040 
                         
Total $47,374,029  $655,601  $(193,006) $10,650,635  $37,185,989  $10,188,040 

The Company has invested in corporate securities, which mature from July 15, 2023 through August 16, 2023, and are held to maturity. The current trading prices or fair market value of the derivativesecurities vary, and we believe any decline in fair value is temporary. All securities are current and not in default.


7.CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, AND INVESTMENT IN AFFILIATE (Continued)

The following table summarizes the amortized cost of the held-to-maturity securities at June 30, 2023, aggregated by credit quality indicator.

Credit Quality Indicators for the Securities   
AA/A   
Corporate Securities  1,856,405 
BBB    
Corporate Securities  1,331,635 
Total $3,188,040 

During the year ended June 30, 2023, the Company recognized interest income pertaining to the investments of $1,035,946 in the financial statements, which is recorded as part of investment income in the statement of operations.

8.INVESTMENTS IN SECURITIES -RELATED PARTY AND BOND RECEIVABLE -RELATED PARTY

The Company over the past year has considered many companies in the hydrogen space for strategic investments, and believed that TECO 2030 ASA (TECO)’s fuel cell technology, designed with their development partner AVL, has shown incredible potential to become a key player in the fuel cell market. On November 11, 2022, the Company (“SunHydrogen”) entered into a subscription agreement with TECO a public limited company incorporated in Norway. Pursuant to the subscription agreement, the Company purchased 13,443,875 shares of TECO stock for an aggregate consideration of $7 million in USD, at an exchange rate of NOK 10.4094. The stocks purchased are adjusted to fair value based on unrealized gain or loss at the end of each period. Sunhydrogen, Inc. has reported TECO as a liabilityrelated party, due to having an 8.3% interest as a shareholder.

The Company purchased a bond receivable of TECO for a subscription amount of $3 million in USD. The issuance of the bond receivable is through a Tap Issue Addendum to TECO’s secured convertible notes agreement dated June 1, 2022, pursuant to which Nordic Trustee AS is acting as the security agent on behalf of the note holders. The bond receivable mature on June 1, 2025, and bears interest at issuancethe rate of 8% per annum paid quarterly in arrears and are convertible into shares of TECO at a rate of NOK 5.0868 per share. For the year ended June 30, 2023, the Company recognized interest income of $113,913 in the financial statements. All interest income has been paid timely each quarter.

The CEO of SunHydrogen is a director of TECO, however it is the percentage of ownership of TECO’s common stock that makes this a related party relationship.

  Cost Basis  Unrealized
Gain
  Fair Value
June 30,
2023
 
Short term equity investments at fair value, related party $7,000,000  $655,601  $7,655,601 

During the year ended June 30, 2023, the Company recognized an unrealized gain of $655,601 in the financial statements.

9.COMMITMENTS AND CONTINGENCIES

Effective October 1, 2022, the Company extended its research agreement with the University of Iowa through September 30, 2023. As consideration under the research agreement, the University of Iowa will receive a maximum of $343,984 from the Company in four equal installments of $85,996. The agreement can be terminated by either party upon sixty (60) days prior written notice to the other. As of June 30, 2023, there remains a balance of $85,996 per the agreement due in the quarter ending September 30, 2023.

Effective October 1, 2022, the Company extended its research agreement with the University of Michigan through September 30, 2023. As consideration under the research agreement, the University of Michigan will receive a maximum of $298,194, from the Company in four equal installments of $74,549. In the event of early termination by the Sponsor, the Sponsor will pay all costs accrued by the University as of the date of termination, including non-cancellable obligations. As of June 30, 2023, there remains a balance of $74,549 per the agreement due in the quarter ending September 30, 2023.

Effective December 2021, the Company entered into a marketing media campaign in the amount of $350,000, during the year ended June 30, 2022. The Company paid $262,500, and the remaining balance of $87,500 was paid on July 11, 2022 leaving a zero balance as of June 30, 2023.


9.COMMITMENTS AND CONTINGENCIES (Continued)

The Company rented lab space with the University of Iowa as of February 2022. The monthly rent was $1,468, plus an additional $500 for the rental of a lab on a month-to-month basis and is cancelable with a thirty (30) day notice. On July 1, 2022, the Company increased the space needed for its’ lab work for a monthly rental of $5,468 per month. Due to the rental being month-to-month, ASC 842 lease accounting is not applicable.

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position or results of operation.

10.RELATED PARTY

As of June 30, 2023, the Company reported an accrual associated with the CEO’s prior years’ salary in the amount of $211,750 for the current year, which is recorded in related party accrued expenses. The Company began accruing the salary in 2011 and used the funds for operating expenses. During the period ended December 31, 2022, the accrued salary was reclassified as a loan from the CEO, with an offset to valuation discount, whichinterest rate of five percent (5%). The loan will be amortizedrepaid with monthly payments of $9,290, including interest and principal over a two-year period. As of June 30, 2023, the lifeprincipal balance remaining on the loan was $143,460, and interest paid during the year was $6,033.

Under the 2019 Equity Incentive Plan, an employee was granted 21,500,000 restricted stock awards at a price of $0.025 per share for services, which vested on March 30, 2023. During the Notes.year ended June 30, 2023, the Company issued 21,500,000 shares of common stock and recorded stock compensation expense of $537,500 reported in the financial statements.

Under the 2022 Equity Incentive Plan, an employee, a director and consultant were granted 33,000,000 restricted stock awards at a price of $0.025 per share for services, whereby 23,000,000 shares vest on January 1, 2023 and the remaining 10,000,000 will vest on January 1,2024. During the year ended, the Company issued 23,000,000 shares of common stock and recorded stock compensation expense of $700,000, as reported in the financial statements.

Under the 2022 Equity Incentive Plan, two employees were granted 150,000,000 restricted stock awards for services, which vested immediately. The Company withheld 62,400,000 shares at a price of $0.027 to pay for the taxes owed by the employees in the amount of $1,684,800, and the remaining 87,600,000 shares priced at $0.027 per share in the amount of $2,365,200 in stock compensation reported in the financial statements.

 

During the year ended June 30, 2020,2023, a consultant exercised 3,071,412 nonqualified stock options through a cashless exercise for $32,875 in stock compensation expense reported in the financial statements.

On November 11, 2022, the Company recorded(“SunHydrogen”) entered into a net losssubscription agreement with TECO a public limited company incorporated in change in derivative of $54,910,562 in the statement of operations dueNorway. Pursuant to the changesubscription agreement, the Company purchased 13,443,875 shares of TECO stock for an aggregate consideration of $7 million in USD, at an exchange rate of NOK 10.4094.

The stocks purchased are adjusted to fair value at the end of each period.

The Company purchased a convertible note of TECO for a subscription amount of $3 million in USD. The issuance of the remainingconvertible note receivable is through a Tap Issue Addendum to TECO’s secured convertible notes foragreement dated June 1, 2022, pursuant to which Nordic Trustee AS is acting as the security agent on behalf of the note holders. The convertible note matures on June 1, 2025, and bears interest at the rate of 8% per annum  paid quarterly in arrears and are convertible into shares of TECO at a rate of NOK 5.0868 per share.  During the year ended June 30, 2020. At June 30, 2020,2023, the fair valueCompany recognized interest income of $113,913 in the derivative liability was $59,657,719.financial statements.

 

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Cox Rubenstein binomial lattice formula. The significant assumptions used in the Cox Rubenstein binomial lattice formula of the derivatives areSunhydrogen, Inc. has reported TECO as follows:a related party, due to having an 8.3% interest as a shareholder.

 

Risk free interest rate11.0.13% - 0.22%
Stock volatility factor80.0% - 267.0%
Weighted average expected option life0 months - 5 year
Expected dividend yieldNone

7.DEFERRED TAX BENEFIT

 

The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2017.2020. 

 

Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amount when the realization is uncertain. Included in the balance at June 30, 20202023 and 2019,2022, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.  Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

 

7.11.DEFERRED TAX BENEFIT (Continued)

 

The Company’s policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periodsyear ended June 30, 20202023 and 2019,2022, the Company did not recognize interest or penalties.

 

At June 30, 2020,2023, the Company had net operating loss carry-forward of approximately $7,722,300,$24,586,700, which expires in future years. No tax benefit has been reported in the June 30, 20202023 and 20192022 financial statements, since the potential tax benefit is offset by a valuation allowance of the same amount.

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended June 30, 20202023 and 20192022 due to the following:

 

 6/30/2020 6/30/2019  6/30/2023  6/30/2022 
Book income (loss) $(12,081,160) $1,193,500  $204,745  $18,912,318 
Non-deductible expenses  11,950,635)  (1,520,850)  1,975,885   (19,517,066)
Depreciation and amortization  310   45   (860)  2,623 
Related party accrual  7,875   (5,100)
Valuation Allowance  122,340   332,405   (2,179,770)  602,125 
                
Income tax expense $-  $-  $-  $- 

 

Deferred taxes are provided on a liability method, whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forward and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Net deferred tax liabilities consist of the following components as of June 30, 20202023 and 2019:2022: 

 

 6/30/2020 6/30/2019  6/30/2023  6/30/2022 
Deferred tax assets:          
NOL carryover $1,571,210  $2,070,125  $(5,163,215) $(3,376,695)
Research and development  104,500   92,490   736,330   452,330 
Related party accrual  44,465   52,275   30,125   44,470 
Deferred tax liabilities:                
Depreciation and amortization $(3,610) $(5,340)  (4,485)  (4,485)
                
Less Valuation Allowance $(1,716,565) $(2,209,550) $4,401,245  $2,884,380 
                
Income tax expense $-  $-  $-  $- 

 

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forward for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forward may be limited as to use in future years.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cut and Jobs Act (the “Tax Act”).  The Tax Act establishes new tax laws that affects 2018 and future years, including a reduction in the U.S. federal corporate income tax rate to 21%, effective July 1, 2018. The Company has applied the new tax law for its calculation of the deferred tax provision. There was no impact to the Company’s financial statements. For certain deferred tax assets and deferred tax liabilities, we have recorded a provisional decrease of $707,468, with a corresponding net adjustment to the valuation allowance of $707,468 as of July 1, 2018.

 

The Company’s tax returns for the previous three years remain open for audit by the respective tax jurisdictions.

 


SUNHYDROGEN, INC.

(formerly Hypersolar, Inc.)

NOTES TO FINANCIAL STATEMENTS - AUDITED

JUNE 30, 2020 AND 2019

12.8.COMMITMENTS AND CONTINGENCIES

On June 1, 2019, the Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $144,747 from the Company. The research agreement may be terminated by either party upon a sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. The term of the research agreement runs through May 31, 2020, and was extended on September 1, 2020.

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations.

9.RELATED PARTY

As of June 30, 2020, the Company reported an accrual associated with the CEO’s prior year salary in the amount of $211,750.

10.SUBSEQUENT EVENTS

 

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855 and reportedhad the following events:subsequent events to report.

 

On July 13, 2020,September 8, 2023, the Company issued 23,420,128221,052,632 shares of common stock upon the conversion of principal2,100 shares of Series C preferred stock with a face value of $210,000 at a conversion price of $0.0095.

On September 21, 2023, the Company issued 18,684,057 shares of common stock per the purchase notice at a price of $0.015354 per share in the amount of $80,000, plus accrued interest of $3,989, and $300 in other fees.

On July 14, 2020,$250,0000, according to the Company issued 1,047,679 shares of common stock for services in the amount of $29,335.

On July 15, 2020, the Company issued 48,802,884 shares of common stock upon conversion of principal in the amount of $33,000, plus accrued interest of $13,363.

On July 27, 2020, the Company entered into a common stock purchase agreement, whereby an investor purchased 20,000,000 shares of common stock at a purchase price of $0.025.agreement.

On August 12, 2020, the Company issued 836,678 shares of common stock for services in the amount of $29,267.

On August 12, 2020, the Company issued 5,294,205 shares of common stock upon conversion of principal in the amount of $80,000, plus accrued interest of $3,989, and $300 in other fees.

On September 1, 2020, the Company entered into a research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $299,966 from the Company. The research agreement may be terminated by either party upon sixty (60) days prior written notice or by either party upon notice of a material breach or default which is not cured within 90 days of receipt of written notice of such breach. This term of the research agreement runs through August 31, 2021, but may be extended upon mutual agreement of the parties.

On September 4, 2020, the Company issued 929,546 shares of common stock for services in the amount of $29,699.

On September 11, 2020, the Company issued 2,390,871 shares of common stock upon conversion of principal in the amount of $40,000, plus accrued interest of $1,994.52 and $300 in other expenses.

 


On September 21, 2020, the Company entered into a purchase agreement (the “Purchase Agreement”) with GHS Investments, LLC (“GHS”). Under the Purchase Agreement, the Company may sell, in its discretion (subject to the terms and conditions of the Purchase Agreement) up to an aggregate of $4,000,000 of common stock to GHS.

 

The Company has the right, in its sole discretion, subject to the conditions and limitations in the Purchase Agreement, to direct GHS, by delivery of a purchase notice from time to time (a “Purchase Notice”) to purchase (each, a “Purchase”) over the 6-month term of the Purchase Agreement, a minimum of $10,000 and up to a maximum of $400,000 (the “Purchase Amount”) of shares of common stock (the “Purchase Shares”) for each Purchase Notice (provided that, the Purchase Amount for any Purchase will not exceed two times the average of the daily trading dollar volume of the common stock during the 10 business days preceding the purchase date). The number of Purchase Shares we will issue under each Purchase will be equal to 112.5% of the Purchase Amount sold under such Purchase, divided by the Purchase Price per share (as defined under the Purchase Agreement). The “Purchase Price” is defined as 90% of the lowest end-of-day volume weighted average price of the common stock for the five consecutive business days immediately preceding the purchase date, including the purchase date. We may not deliver more than one Purchase Notice to GHS every ten business days, except as the parties may otherwise agree.F-19

Other than as described above, there are no trading volume requirements or restrictions under the Purchase Agreement. We will control the timing and amount of any sales of our common stock to GHS. We may at any time in our sole discretion terminate the Purchase Agreement.

The Purchase Agreement prohibits us from directing GHS to purchase any shares of common stock if those shares, when aggregated with all other shares of our common stock then beneficially owned by GHS and its affiliates, would result in GHS and its affiliates having beneficial ownership, at any single point in time, of more than 4.99% of the then total outstanding shares of our common stock.

Events of default under the Purchase Agreement include the following:

the effectiveness of the registration statement for the Purchase Shares lapses for any reason or is unavailable for the resale by GHS of the Purchase Shares;

the suspension of our common stock from trading for a period of two business days;

the delisting of the Company’s common stock from the OTC Pink; provided, however, that the common stock is not immediately thereafter trading on the Nasdaq Capital Market, New York Stock Exchange, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American, or the OTCQX or OTCQB;

the failure for any reason by the transfer agent to issue Purchase Shares to GHS within three business days after the applicable date on which GHS is entitled to receive such securities;

any breach of the representations and warranties or covenants contained in the Purchase Agreement if such breach would reasonably be expected to have a material adverse effect and such breach is not cured within five business days;

insolvency or bankruptcy proceedings are commenced by or against us, as more fully described in the Purchase Agreement; or

if at any time we are not eligible to transfer our common stock electronically via DWAC.

So long as an event of default (all of which are outside the control of GHS) has occurred and is continuing, the Company may not deliver to GHS any Purchase Notice.

We will pay a finder’s fee to J.H. Darbie & Co., Inc. of 4% of the net proceeds we receive from sales of our common stock to GHS under the Purchase Agreement.

F-21

 

NONE 27940000 2500000 false FY 0001481028 iso4217:INR xbrli:shares